BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758-2769. [PMID: 19553649 DOI: 10.1056/nejmra0805786] [Cited by in Crossref: 631] [Cited by in F6Publishing: 673] [Article Influence: 45.1] [Reference Citation Analysis]
Number Citing Articles
1 Allende DS, Yerian LM. Non-Neoplastic Disorders of the Liver. Gastrointestinal and Liver Pathology 2024. [DOI: 10.1016/b978-0-323-52794-1.00017-1] [Reference Citation Analysis]
2 Tu W, Gawrieh S, Dasarathy S, Mitchell MC, Simonetto DA, Patidar KR, McClain CJ, Bataller R, Szabo G, Tang Q, Barton BA, Radaeva S, Sanyal AJ, Shah V; Alcoholic Hepatitis Network (AlcHepNet) Investigators. Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis. Contemp Clin Trials Commun 2023;32:101074. [PMID: 36698742 DOI: 10.1016/j.conctc.2023.101074] [Reference Citation Analysis]
3 Hardesty JE, Warner JB, Song YL, Rouchka EC, McClain CJ, Warner DR, Kirpich IA. Resolvin D1 attenuated liver injury caused by chronic ethanol and acute LPS challenge in mice. FASEB J 2023;37:e22705. [PMID: 36520060 DOI: 10.1096/fj.202200778R] [Reference Citation Analysis]
4 Zhu L, Xu J, Li H, Li J, Cheng M, Niu X, Jia P, Liu J, Huang C, Lv X, Li J. Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate–Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease. Laboratory Investigation 2023. [DOI: 10.1016/j.labinv.2022.100041] [Reference Citation Analysis]
5 Ntandja Wandji LC, Ningarhari M, Lassailly G, Dharancy S, Boleslawski E, Mathurin P, Louvet A. Liver Transplantation in Alcohol-related Liver Disease and Alcohol-related Hepatitis. J Clin Exp Hepatol 2023;13:127-38. [PMID: 36647412 DOI: 10.1016/j.jceh.2022.06.013] [Reference Citation Analysis]
6 Hernandez-Tejero M, Clemente-Sanchez A, Bataller R. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease. J Clin Exp Hepatol 2023;13:75-87. [PMID: 36647416 DOI: 10.1016/j.jceh.2022.10.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wakil A, Niazi M, Meybodi MA, Pyrsopoulos NT. Emerging Pharmacotherapies in Alcohol-Associated Hepatitis. J Clin Exp Hepatol 2023;13:116-26. [PMID: 36647403 DOI: 10.1016/j.jceh.2022.06.012] [Reference Citation Analysis]
8 Bataller R, Arab JP, Shah VH. Alcohol-Associated Hepatitis. N Engl J Med 2022;387:2436-48. [PMID: 36577100 DOI: 10.1056/NEJMra2207599] [Reference Citation Analysis]
9 Durkin C, Bittermann T. Liver transplantation for alcohol-associated hepatitis. Curr Opin Organ Transplant 2022. [PMID: 36512482 DOI: 10.1097/MOT.0000000000001044] [Reference Citation Analysis]
10 Mackowiak B, Xu M, Lin Y, Guan Y, Seo W, Ren R, Feng D, Jones JW, Wang H, Gao B. Hepatic CYP2B10 is highly induced by binge ethanol and contributes to acute-on-chronic alcohol-induced liver injury. Alcohol Clin Exp Res 2022;46:2163-76. [PMID: 36224745 DOI: 10.1111/acer.14954] [Reference Citation Analysis]
11 Argemi J, Kedia K, Gritsenko MA, Clemente-Sanchez A, Asghar A, Herranz JM, Liu ZX, Atkinson SR, Smith RD, Norden-Krichmar TM, Day LZ, Stolz A, Tayek JA, Bataller R, Morgan TR, Jacobs JM; Southern California Alcoholic Hepatitis Consortium and the InTeam Consortium. Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis. Am J Pathol 2022;192:1658-69. [PMID: 36243044 DOI: 10.1016/j.ajpath.2022.08.009] [Reference Citation Analysis]
12 Han H, Jin W, Li X. Mesenchymal stem cells-based therapy in liver diseases. Mol Biomed 2022;3:23. [DOI: 10.1186/s43556-022-00088-x] [Reference Citation Analysis]
13 Manchel A, Mahadevan R, Bataller R, Hoek JB, Vadigepalli R. Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic Hepatitis. Metabolites 2022;12. [PMID: 36557195 DOI: 10.3390/metabo12121157] [Reference Citation Analysis]
14 Kai Kou, Xiaodong Sun, Guangyao Tian, Yao Zhi, Zhongqi Fan, Guoyue Lv. The Mechanisms of Systemic Inflammatory and Immunosuppressive Acute-on-Chronic Liver Failure and Application Prospect of Single-Cell Sequencing. J Immunol Res 2022;2022:5091275. [PMID: 36387424 DOI: 10.1155/2022/5091275] [Reference Citation Analysis]
15 Asensio M, Ortiz-rivero S, Morente-carrasco A, Marin JJG. Etiopathogenesis and pathophysiology of cholestasis. Explor Dig Dis 2022. [DOI: 10.37349/edd.2022.00008] [Reference Citation Analysis]
16 Tayek JA, Stolz AA, Nguyen DV, Fleischman MW, Donovan JA, Alcorn JM, Chao DC, Asghar A, Morgan TR; Southern California Alcoholic Hepatitis (SCAH) Consortium. A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis. EClinicalMedicine 2022;54:101689. [PMID: 36267499 DOI: 10.1016/j.eclinm.2022.101689] [Reference Citation Analysis]
17 Ha Y, Jeong I, Kim TH. Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives. Biomedicines 2022;10:2530. [PMID: 36289791 DOI: 10.3390/biomedicines10102530] [Reference Citation Analysis]
18 Lucey MR, Thursz MR. We need a new approach to clinical trials in alcohol-associated hepatitis: Is there a lesson in RECOVERY? Hepatology 2022;76:909-10. [PMID: 35416316 DOI: 10.1002/hep.32523] [Reference Citation Analysis]
19 Warner JB, Guenthner SC, Hardesty JE, McClain CJ, Warner DR, Kirpich IA. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World J Gastroenterol 2022; 28(36): 5280-5299 [DOI: 10.3748/wjg.v28.i36.5280] [Reference Citation Analysis]
20 Wakil A, Mohamed M, Tafesh Z, Niazi M, Olivo R, Xia W, Greenberg P, Pyrsopoulos N. Trends in hospitalization for alcoholic hepatitis from 2011 to 2017: A USA nationwide study. World J Gastroenterol 2022; 28(34): 5036-5046 [DOI: 10.3748/wjg.v28.i34.5036] [Reference Citation Analysis]
21 Zhao X, Zhou M, Deng Y, Guo C, Liao L, He L, Peng C, Li Y. Functional Teas from Penthorum chinense Pursh Alleviates Ethanol-Induced Hepatic Oxidative Stress and Autophagy Impairment in Zebrafish via Modulating the AMPK/p62/Nrf2/mTOR Signaling Axis. Plant Foods Hum Nutr. [DOI: 10.1007/s11130-022-01010-0] [Reference Citation Analysis]
22 Cho Y, Bukong TN, Tornai D, Babuta M, Vlachos IS, Kanata E, Catalano D, Szabo G. Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis. J Hepatol 2022:S0168-8278(22)03060-4. [PMID: 36063965 DOI: 10.1016/j.jhep.2022.08.029] [Reference Citation Analysis]
23 Authors, Collaborators:. Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025. Z Gastroenterol 2022;60:e733-e801. [DOI: 10.1055/a-1880-2388] [Reference Citation Analysis]
24 Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, Denzer UW, Geier A, Hofmann WP, Hudert C, Karlas T, Krawczyk M, Longerich T, Luedde T, Roden M, Schattenberg J, Sterneck M, Tannapfel A, Lorenz P, Tacke F; Collaborators:. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Z Gastroenterol 2022;60:1346-421. [PMID: 36100202 DOI: 10.1055/a-1880-2283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
25 Mirijello A, Sestito L, Antonelli M, Gasbarrini A, Addolorato G. Identification and management of acute alcohol intoxication. Eur J Intern Med 2022:S0953-6205(22)00291-6. [PMID: 35985955 DOI: 10.1016/j.ejim.2022.08.013] [Reference Citation Analysis]
26 Du Y, Yang C, Ren D, Shao H, Zhao Y, Yang X. Fu brick tea alleviates alcoholic liver injury by modulating the gut microbiota-liver axis and inhibiting the hepatic TLR4/NF-κB signaling pathway. Food Funct 2022. [PMID: 35959866 DOI: 10.1039/d2fo01547a] [Reference Citation Analysis]
27 Xue Y, Li X, Tian Y, Huang X, Zhang L, Li J, Hou H, Dong P, Wang J. Salmon sperm DNA prevents acute liver injury by regulating alcohol‐induced steatosis and restores chronic hepatosis via alleviating inflammation and apoptosis. Journal of Food Biochemistry. [DOI: 10.1111/jfbc.14346] [Reference Citation Analysis]
28 Carvalho-Gontijo R, Han C, Zhang L, Zhang V, Hosseini M, Mekeel K, Schnabl B, Loomba R, Karin M, Brenner DA, Kisseleva T. Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD. Semin Liver Dis 2022;42:233-49. [PMID: 36001995 DOI: 10.1055/s-0042-1755316] [Reference Citation Analysis]
29 Gupta H, Kim SH, Kim SK, Han SH, Kwon HC, Suk KT. Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis. Microorganisms 2022;10:1474. [DOI: 10.3390/microorganisms10071474] [Reference Citation Analysis]
30 Mueller S, Chen C, Mueller J, Wang S. Novel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis. Journal of Translational Internal Medicine 2022;0. [DOI: 10.2478/jtim-2021-0056] [Reference Citation Analysis]
31 Rattan P, Shah VH. Review article: current and emerging therapies for acute alcohol-associated hepatitis. Aliment Pharmacol Ther 2022;56:28-40. [PMID: 35567372 DOI: 10.1111/apt.16969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Hardesty J, Day L, Warner J, Warner D, Gritsenko M, Asghar A, Stolz A, Morgan T, McClain C, Jacobs J, Kirpich I. Hepatic Protein and Phosphoprotein Signatures of Alcohol-Associated Cirrhosis and Hepatitis. Am J Pathol 2022;192:1066-82. [PMID: 35490715 DOI: 10.1016/j.ajpath.2022.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Vaz K, Little R, Majeed A, Kemp W, Roberts SK. Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis. Dig Dis Sci 2022;67:3356-65. [PMID: 34231100 DOI: 10.1007/s10620-021-07140-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Yen Y, Park J, Kang S, Su T, Cheng H, Wen W, Lin S, Tai Y, Chen P, Tsai S. Clinical Benefits of Golden-Antrodia Camphorata Containing Antroquinonol in Liver Protection and Liver Fat Reduction After Alcoholic Hepatitis. Front Pharmacol 2022;13:757494. [DOI: 10.3389/fphar.2022.757494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Zhao L, Wang S, Zhang N, Zhou J, Mehmood A, Raka RN, Zhou F, Zhao L. The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease. Antioxidants (Basel) 2022;11:1211. [PMID: 35740108 DOI: 10.3390/antiox11061211] [Reference Citation Analysis]
36 Liu Z, Zhao J, Sun R, Wang M, Wang K, Li Y, Shang H, Hou J, Jiang Z. Lactobacillus plantarum 23-1 improves intestinal inflammation and barrier function through the TLR4/NF-κB signaling pathway in obese mice. Food Funct 2022;13:5971-86. [PMID: 35546499 DOI: 10.1039/d1fo04316a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
37 Patel D, Sharma D, Mandal P. Gut Microbiota: Target for Modulation of Gut-Liver-Adipose Tissue Axis in Ethanol-Induced Liver Disease. Mediators Inflamm 2022;2022:4230599. [PMID: 35633655 DOI: 10.1155/2022/4230599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Szabo G, Thursz M, Shah VH. Therapeutic advances in alcohol-associated hepatitis. J Hepatol 2022;76:1279-90. [PMID: 35589250 DOI: 10.1016/j.jhep.2022.03.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Liu SX, Liu H, Wang S, Zhang CL, Guo FF, Zeng T. Diallyl disulfide ameliorates ethanol-induced liver steatosis and inflammation by maintaining the fatty acid catabolism and regulating the gut-liver axis. Food Chem Toxicol 2022;:113108. [PMID: 35526736 DOI: 10.1016/j.fct.2022.113108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Madácsy T, Varga Á, Papp N, Tél B, Pallagi P, Szabó V, Kiss A, Fanczal J, Rakonczay Z Jr, Tiszlavicz L, Rázga Z, Hohwieler M, Kleger A, Gray M, Hegyi P, Maléth J. Impaired regulation of PMCA activity by defective CFTR expression promotes epithelial cell damage in alcoholic pancreatitis and hepatitis. Cell Mol Life Sci 2022;79:265. [PMID: 35484438 DOI: 10.1007/s00018-022-04287-1] [Reference Citation Analysis]
41 Lin Y, Kong D, Zhang Y. Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy? Front Oncol 2022;12:852194. [DOI: 10.3389/fonc.2022.852194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Charkoftaki G, Tan WY, Berrios-carcamo P, Orlicky DJ, Golla JP, Garcia-milian R, Aalizadeh R, Thomaidis NS, Thompson DC, Vasiliou V. Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Malaguarnera G, Catania VE, Bertino G, Drago F, Madeddu R, Bonfiglio C, Malaguarnera M. Serum Folate deficiency in HCV related Hepatocellular Carcinoma. Sci Rep 2022;12:5025. [PMID: 35322130 DOI: 10.1038/s41598-022-09030-1] [Reference Citation Analysis]
44 Schulz MS, Gu W, Schnitzbauer AA, Trebicka J. Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure. Transpl Int 2022;35:10108. [DOI: 10.3389/ti.2022.10108] [Reference Citation Analysis]
45 Sandoval C, Farías J, Zamorano M, Herrera C. Vitamin Supplements as a Nutritional Strategy against Chronic Alcohol Consumption? An Updated Review. Antioxidants 2022;11:564. [DOI: 10.3390/antiox11030564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Zakareya T, Akl M, Shibl S, El-mazaly M, Abdel-razek W. Utility of prognostic scores in predicting short-term mortality in patients with acute-on-chronic liver failure. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00183-2] [Reference Citation Analysis]
47 Abbasy M, Zaghla H, Elhelbawy M, Ramadan M, Zakareya T. Predicting in-hospital mortality of cirrhotic patients hospitalized with hepatic encephalopathy. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00178-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Parker R, Cabezas J, Altamirano J, Arab JP, Ventura-Cots M, Sinha A, Dhanda A, Arrese M, McCune CA, Rowe IA, Schnabl B, Mathurin P, Shawcross D, Abraldes JG, Lucey MR, Garcia-Tsao G, Verna E, Brown RS Jr, Bosques-Padilla F, Vargas V, Louvet A, Holt AP, Bataller R. Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2022;20:e289-97. [PMID: 33516950 DOI: 10.1016/j.cgh.2021.01.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
49 Morales-Arráez D, Ventura-Cots M, Altamirano J, Abraldes JG, Cruz-Lemini M, Thursz MR, Atkinson SR, Sarin SK, Kim W, Chavez-Araujo R, Higuera-de la Tijera MF, Singal AK, Shah VH, Kamath PS, Duarte-Rojo A, Charles EA, Vargas V, Jager M, Rautou PE, Rincon D, Zamarripa F, Restrepo-Gutiérrez JC, Torre A, Lucey MR, Arab JP, Mathurin P, Louvet A, García-Tsao G, González JA, Verna EC, Brown RS Jr, Argemi J, Fernández-Carrillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study. Am J Gastroenterol 2022;117:301-10. [PMID: 34962498 DOI: 10.14309/ajg.0000000000001596] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
50 Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, Rinella M, Schiano TD, Lucey MR, Terrault N. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2022;20:409-418.e5. [PMID: 33279780 DOI: 10.1016/j.cgh.2020.11.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
51 Kim KY, Kim JO, Kim YS, Choi JE, Park JM, Han K, Park DH, Park YC, Kim BT, Hong KW. Genome-wide association of individual vulnerability with alcohol-associated liver disease: A Korean genome and epidemiology study. Hepatology 2022;75:391-402. [PMID: 34387878 DOI: 10.1002/hep.32115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
52 Mao J, Zhan H, Meng F, Wang G, Huang D, Liao Z, Chen M. Costunolide protects against alcohol-induced liver injury by regulating gut microbiota, oxidative stress and attenuating inflammation in vivo and in vitro. Phytother Res 2022. [PMID: 35084790 DOI: 10.1002/ptr.7383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Miño Bernal JF, López Morales E, Sandino NJ, Molano Franco D. Cirrosis hepática o falla hepática crónica agudizada: definición y clasificación. Repert Med Cir 2022;31:112-122. [DOI: 10.31260/repertmedcir.01217372.1052] [Reference Citation Analysis]
54 Yang YM, Cho YE, Hwang S. Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease. Int J Mol Sci 2022;23:774. [PMID: 35054960 DOI: 10.3390/ijms23020774] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
55 Zheng LY, Zou X, Wang YL, Zou M, Ma F, Wang N, Li JW, Wang MS, Hung HY, Wang Q. Betulinic acid-nucleoside hybrid prevents acute alcohol -induced liver damage by promoting anti-oxidative stress and autophagy. Eur J Pharmacol 2022;914:174686. [PMID: 34883073 DOI: 10.1016/j.ejphar.2021.174686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
56 Nath P, Anand AC. Extrahepatic Manifestations in Alcoholic Liver Disease. J Clin Exp Hepatol 2022;12:1371-83. [PMID: 36157144 DOI: 10.1016/j.jceh.2022.02.004] [Reference Citation Analysis]
57 Contreras-omaña R, Velarde-ruiz Velasco J, Castro-narro G, Trujillo-benavides O, Zamarripa-dorsey F, Reyes-dorantes A, Muñoz-espinosa L, Aiza-haddad I, Castillo-barradas M, Cerda-reyes E, Cisneros-garza L, Flores-calderón J, García-jiménez E, Higuera-de-la-tijera M, Lira-pedrín M, Marquez-guillén E, Moctezuma-velázquez C, Moreno-alcántar R, Noyola-cedillo S, Pérez-hernández J, Ramos-gómez M, Remes-troche J, Rizo-robles M, Rodríguez-hernández H. Abordaje del paciente con colestasis y síndrome ictérico. Posicionamiento científico conjunto AMH, AMG, AMEG. Revista de Gastroenterología de México 2022;87:80-88. [DOI: 10.1016/j.rgmx.2021.04.006] [Reference Citation Analysis]
58 Jophlin L, Singal AK. Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure. J Clin Exp Hepatol 2022;12:544-50. [PMID: 35535109 DOI: 10.1016/j.jceh.2021.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Gelu-simeon M, Mathurin P. Acute Alcoholic Hepatitis: Indication for Early Liver Transplantation. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_4] [Reference Citation Analysis]
60 Khan S, Cain O, Rajoriya N. Alcohol Related Liver Disease. Men’s Health and Wellbeing 2022. [DOI: 10.1007/978-3-030-84752-4_11] [Reference Citation Analysis]
61 Weinrieb RM, Strong MA. Psychiatric Evaluation of the Liver Transplant Candidate with Alcohol-Associated Hepatitis. Transplant Psychiatry 2022. [DOI: 10.1007/978-3-031-15052-4_18] [Reference Citation Analysis]
62 Adesina E, Oyero O, Okorie N, Ben-enukora C, Adeyeye B. Risk Communication for Viral Hepatitis Management Among Migrants. Research Anthology on Improving Health Literacy Through Patient Communication and Mass Media 2022. [DOI: 10.4018/978-1-6684-2414-8.ch002] [Reference Citation Analysis]
63 Ballester MP, Sittner R, Jalan R. Alcohol and Acute-on-Chronic Liver Failure. J Clin Exp Hepatol 2022;12:1360-70. [PMID: 36157143 DOI: 10.1016/j.jceh.2021.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Staudacher J, Bauer J, Atkinson S, Thursz M, Lang S, Schnabl B, Wiley M, Carr R, Jung B. Systemic Activin Is Elevated in Patients With Severe Alcoholic Hepatitis. Gastro Hep Advances 2022;1:147-149. [DOI: 10.1016/j.gastha.2021.12.004] [Reference Citation Analysis]
65 Muriel P. Alcohol-induced liver fibrosis. Hepatic Fibrosis 2022. [DOI: 10.1016/b978-0-323-99764-5.00008-1] [Reference Citation Analysis]
66 Fang C, Zhou Q, Liu Q, Jia W, Xu Y. Crosstalk between gut microbiota and host lipid metabolism in a mouse model of alcoholic liver injury by chronic baijiu or ethanol feeding. Food Funct 2021. [PMID: 34927188 DOI: 10.1039/d1fo02892h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Luo J, Zhang J, Lai W, Wang S, Zhou L, Shi Y, Ba J, Hu J, Wang Y, Li L, Wu B. Disseminated Human Parvovirus B19 Infection Induced Multiple Organ Dysfunction Syndrome in an Adult Patient With Alcoholic Hepatitis Complicated by Hemolytic Anemia: A Case Report and Literature Review. Front Immunol 2021;12. [DOI: 10.3389/fimmu.2021.742990] [Reference Citation Analysis]
68 Duan Y, Chu H, Brandl K, Jiang L, Zeng S, Meshgin N, Papachristoforou E, Argemi J, Mendes BG, Wang Y, Su H, Sun W, Llorente C, Hendrikx T, Liu X, Hosseini M, Kisseleva T, Brenner DA, Bataller R, Ramachandran P, Karin M, Fu W, Schnabl B. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat Commun 2021;12:7172. [PMID: 34887405 DOI: 10.1038/s41467-021-27385-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
69 Contreras-Omaña R, Velarde-Ruiz Velasco JA, Castro-Narro GE, Trujillo-Benavides O, Zamarripa-Dorsey F, Reyes-Dorantes AA, Muñoz-Espinosa L, Aiza-Haddad I, Castillo-Barradas M, Cerda-Reyes E, Cisneros-Garza LE, Flores-Calderón J, García-Jiménez ES, Higuera-de-la-Tijera MF, Lira-Pedrín MA, Marquez-Guillén E, Moctezuma-Velázquez C, Moreno-Alcántar R, Noyola-Cedillo SG, Pérez-Hernández JL, Ramos-Gómez MV, Remes-Troche JM, Rizo-Robles MT, Rodríguez-Hernández H. Approach to the patient with cholestasis and jaundice syndrome. Joint AMH, AMG, and AMEG scientific position statement. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00130-4. [PMID: 34866042 DOI: 10.1016/j.rgmxen.2021.04.003] [Reference Citation Analysis]
70 Laroia ST, Vellore Srinivasan S, Yadav K, Rastogi A, Kumar S, Kumar G, Kumar M. Performance of shear wave elastography: A single centre pilot study of mixed etiology liver disease patients with normal BMI. Australas J Ultrasound Med 2021;24:120-36. [PMID: 34765422 DOI: 10.1002/ajum.12244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Vergis N, Patel V, Bogdanowicz K, Czyzewska-Khan J, Fiorentino F, Day E, Cross M, Foster N, Lord E, Goldin R, Forrest E, Thursz M. IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis. Trials 2021;22:792. [PMID: 34763711 DOI: 10.1186/s13063-021-05719-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Ahn J, Sim S, Jeong S, Shin Y, Kim K, Moon B, Yun J. A Case Report of Alcoholic Liver Disease with Jaundice Treated with Korean Medicine. J Int Korean Med 2021;42:949-957. [DOI: 10.22246/jikm.2021.42.5.949] [Reference Citation Analysis]
73 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Islek A, Tumgor G. Acute-on-chronic liver failure in children. World J Hepatol 2021; 13(10): 1289-1298 [PMID: 34786166 DOI: 10.4254/wjh.v13.i10.1289] [Reference Citation Analysis]
75 Yeh CW, Wu WJ, Lu CW, Wang SE, Chuang WC, Lee MC, Wu CH. Traditional Chinese Medicine Yang-Gan-Wan Alleviated Experimental Hepatic Damage by Inhibiting Oxidation, Inflammation, and Apoptosis in Cell and Mouse Models. Evid Based Complement Alternat Med 2021;2021:2556352. [PMID: 34659428 DOI: 10.1155/2021/2556352] [Reference Citation Analysis]
76 Pushilal A, Kalita KN. A Comparative Study of Liver Function Test in a Group of Persons with Alcohol Dependence Disorder. Eastern Journal of Psychiatry 2021;12:21-27. [DOI: 10.5005/ejp-12-1--2-21] [Reference Citation Analysis]
77 Pandey G, Singh H, Chaturvedi S, Hatti M, Kumar A, Mishra R, Mishra P, Krishna VP, Bhadauria A, Mohindra S, Misra DP, Saraswat VA, Agarwal V. Utility of neutrophil CD64 in distinguishing bacterial infection from inflammation in severe alcoholic hepatitis fulfilling SIRS criteria. Sci Rep 2021;11:19726. [PMID: 34611256 DOI: 10.1038/s41598-021-99276-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
78 Musto JA, Eickhoff J, Ventura-Cots M, Abraldes JG, Bosques-Padilla F, Verna EC, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross D, Louvet A, Mathurin P, Garcia-Tsao G, Schnabl B, Bataller R, Lucey MR. The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated Hepatitis. Liver Transpl 2021;27:1382-91. [PMID: 34109723 DOI: 10.1002/lt.26203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Bou Saleh M, Louvet A, Ntandja-Wandji LC, Boleslawski E, Gnemmi V, Lassailly G, Truant S, Maggiotto F, Ningarhari M, Artru F, Anglo E, Sancho-Bru P, Corlu A, Argemi J, Dubois-Chevalier J, Dharancy S, Eeckhoute J, Bataller R, Mathurin P, Dubuquoy L. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis. J Hepatol 2021;75:912-23. [PMID: 34129887 DOI: 10.1016/j.jhep.2021.05.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
80 Lackner C, Stauber RE, Davies S, Denk H, Dienes HP, Gnemmi V, Guido M, Miquel R, Paradis V, Schirmacher P, Terracciano L, Berghold A, Pregartner G, Binder L, Douschan P, Rainer F, Sygulla S, Jager M, Rautou PE, Bumbu A, Horhat A, Rusu I, Stefanescu H, Detlefsen S, Krag A, Thiele M, Cortez-Pinto H, Moreno C, Gouw ASH, Tiniakos DG. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. J Hepatol 2021;75:810-9. [PMID: 34126105 DOI: 10.1016/j.jhep.2021.05.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
81 Van J, Aloman C, Reau N. Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease. Am J Gastroenterol 2021;116:2089-97. [PMID: 34193797 DOI: 10.14309/ajg.0000000000001349] [Reference Citation Analysis]
82 Gougol A, Clemente-Sanchez A, Argemi J, Bataller R. Alcoholic Hepatitis. Clin Liver Dis (Hoboken) 2021;18:90-5. [PMID: 34584675 DOI: 10.1002/cld.1092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Gambino C, Piano S, Angeli P. Acute-on-Chronic Liver Failure in Cirrhosis. J Clin Med 2021;10:4406. [PMID: 34640424 DOI: 10.3390/jcm10194406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Robateau A, Akusoba C, Greenlund L. 51-Year-Old Man With Ascites and Abdominal Pain. Mayo Clin Proc 2021;96:2713-7. [PMID: 34531062 DOI: 10.1016/j.mayocp.2021.01.040] [Reference Citation Analysis]
85 Kang H, Kim MB, Park YK, Lee JY. A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD+ metabolism upon alcohol withdrawal. J Nutr Biochem 2022;99:108852. [PMID: 34525389 DOI: 10.1016/j.jnutbio.2021.108852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Mathurin P. Early liver transplantation for acute alcoholic hepatitis: We can't say no. J Hepatol 2021;75:718-22. [PMID: 34058297 DOI: 10.1016/j.jhep.2021.05.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
87 Shamseddeen H, Madathanapalli A, Are VS, Shah VH, Sanyal AJ, Tang Q, Liang T, Gelow K, Zimmers TA, Chalasani N, Desai AP. Changes in Serum Myostatin Levels in Alcoholic Hepatitis Correlate with Improvement in MELD. Dig Dis Sci 2021;66:3062-73. [PMID: 33074470 DOI: 10.1007/s10620-020-06632-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Herrick-Reynolds KM, Punchhi G, Greenberg RS, Strauss AT, Boyarsky BJ, Weeks-Groh SR, Krach MR, Anders RA, Gurakar A, Chen PH, Segev DL, King EA, Philosophe B, Ottman SE, Wesson RN, Garonzik-Wang JM, Cameron AM. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA Surg 2021. [PMID: 34379106 DOI: 10.1001/jamasurg.2021.3748] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
89 Mitra A, Myers L, Ahn J. Assessing the Severity and Prognosis of Alcoholic Hepatitis. Clin Liver Dis 2021;25:585-93. [PMID: 34229841 DOI: 10.1016/j.cld.2021.03.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Thanda Han MA, Pyrsopoulos N. Emerging Therapies for Alcoholic Hepatitis. Clin Liver Dis 2021;25:603-24. [PMID: 34229843 DOI: 10.1016/j.cld.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Arab JP, Arrese M, Singal AK. Diagnosis of Alcohol-Associated Hepatitis: When Is Liver Biopsy Required? Clin Liver Dis 2021;25:571-84. [PMID: 34229840 DOI: 10.1016/j.cld.2021.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
92 Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA 2021;326:165-76. [PMID: 34255003 DOI: 10.1001/jama.2021.7683] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 22.0] [Reference Citation Analysis]
93 Yan J, Nie Y, Luo M, Chen Z, He B. Natural Compounds: A Potential Treatment for Alcoholic Liver Disease? Front Pharmacol 2021;12:694475. [PMID: 34290612 DOI: 10.3389/fphar.2021.694475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
94 Lim Y, Ku NO. Revealing the Roles of Keratin 8/18-Associated Signaling Proteins Involved in the Development of Hepatocellular Carcinoma. Int J Mol Sci 2021;22:6401. [PMID: 34203895 DOI: 10.3390/ijms22126401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Paek S, Lee S, Park JS, Kim J, Park D. The Effects of Turmeric Intake Alone or in Combination with Resistance Training on Liver Enzymes in Adult Men. Exerc Sci 2021;30:183-191. [DOI: 10.15857/ksep.2021.30.2.183] [Reference Citation Analysis]
96 Foncea CG, Sporea I, Lupușoru R, Moga TV, Bende F, Șirli R, Popescu A. Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis. J Clin Med 2021;10:2338. [PMID: 34071799 DOI: 10.3390/jcm10112338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Wu T, Shah V. Biomarkers of endothelial dysfunction in alcoholic hepatitis. Hepatol Int 2021;15:855-7. [PMID: 34043159 DOI: 10.1007/s12072-021-10202-w] [Reference Citation Analysis]
98 Kim W, Jeong HS, Kim SC, Choi CH, Lee KH. Chronic Alcohol Exposure of Cells Using Controlled Alcohol-Releasing Capillaries. Cells 2021;10:1120. [PMID: 34066517 DOI: 10.3390/cells10051120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Doshi SD, Stotts MJ, Hubbard RA, Goldberg DS. The Changing Burden of Alcoholic Hepatitis: Rising Incidence and Associations with Age, Gender, Race, and Geography. Dig Dis Sci 2021;66:1707-14. [PMID: 32436122 DOI: 10.1007/s10620-020-06346-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
100 German MN, Musto J, Lucey MR. Novel treatments for alcoholic hepatitis. Curr Opin Gastroenterol 2021;37:179-86. [PMID: 33769374 DOI: 10.1097/MOG.0000000000000725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Kwon TJ, Kang W, Gwak G, Paik Y, Choi MS, Lee JH, Koh KC, Sinn DH, Paik SW. Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea. Korean Journal of Transplantation 2021;35:24-32. [DOI: 10.4285/kjt.20.0054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 2021;18:151-66. [PMID: 33128017 DOI: 10.1038/s41575-020-00372-7] [Cited by in Crossref: 274] [Cited by in F6Publishing: 262] [Article Influence: 137.0] [Reference Citation Analysis]
103 Warner D, Vatsalya V, Zirnheld KH, Warner JB, Hardesty JE, Umhau JC, McClain CJ, Maddipati K, Kirpich IA. Linoleic Acid-Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol-Associated Liver Injury. Hepatol Commun 2021;5:947-60. [PMID: 34141982 DOI: 10.1002/hep4.1686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
104 Takeuchi M, Vidigal PT, Guerra MT, Hundt MA, Robert ME, Olave-Martinez M, Aoki S, Khamphaya T, Kersten R, Kruglov E, de la Rosa Rodriguez R, Banales JM, Nathanson MH, Weerachayaphorn J. Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis. Gut 2021;70:342-56. [PMID: 33214166 DOI: 10.1136/gutjnl-2020-322540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
105 Sehrawat TS, Arab JP, Liu M, Amrollahi P, Wan M, Fan J, Nakao Y, Pose E, Navarro-Corcuera A, Dasgupta D, Liao CY, He L, Mauer AS, Avitabile E, Ventura-Cots M, Bataller RA, Sanyal AJ, Chalasani NP, Heimbach JK, Watt KD, Gores GJ, Gines P, Kamath PS, Simonetto DA, Hu TY, Shah VH, Malhi H. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis. Hepatology 2021;73:571-85. [PMID: 32246544 DOI: 10.1002/hep.31256] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
106 Powell J, Michael A. Peri-operative derangement in liver function tests in older patients with neck of femur fracture. Osteoporos Int 2021;32:1027-30. [PMID: 33462651 DOI: 10.1007/s00198-021-05827-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Caputo F, Testino G. Orthotopic liver transplantation for patients with end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis. Minerva Surg 2021;76:444-9. [PMID: 33433074 DOI: 10.23736/S2724-5691.20.08685-X] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Lefkowitch JH. Steatosis, Steatohepatitis and Related Conditions. Scheuer's Liver Biopsy Interpretation 2021. [DOI: 10.1016/b978-0-7020-7584-1.00007-3] [Reference Citation Analysis]
109 Mavilia MG, Wu GY. Hepatitis. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-72592-1_8] [Reference Citation Analysis]
110 Dix HM, Robinson EM, Dillon JF. Liver Disorders Related to Alcohol and Other Drug Use. Textbook of Addiction Treatment 2021. [DOI: 10.1007/978-3-030-36391-8_77] [Reference Citation Analysis]
111 Wang Q, Kim SY, Matsushita H, Wang Z, Pandyarajan V, Matsuda M, Ohashi K, Tsuchiya T, Roh YS, Kiani C, Zhao Y, Chan M, Devkota S, Lu SC, Hayashi T, Carson DA, Seki E. Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22. Proc Natl Acad Sci U S A 2021;118:e2020868118. [PMID: 33443222 DOI: 10.1073/pnas.2020868118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
112 Jung J, Rosoff DB, Muench C, Luo A, Longley M, Lee J, Charlet K, Lohoff FW. Adverse Childhood Experiences are Associated with High-Intensity Binge Drinking Behavior in Adulthood and Mediated by Psychiatric Disorders. Alcohol Alcohol 2020;55:204-14. [PMID: 31895420 DOI: 10.1093/alcalc/agz098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
113 Kotkas IE, Enukashvili NI, Asadulayev SM, Chubar’ AV. The effectiveness of autologous mesenchymal stem cells in the treatment of liver cirrhosis and the method of their visualization in the patient’s body. Bulletin of the Russian Military Medical Academy 2020;22:35-40. [DOI: 10.17816/brmma50528] [Reference Citation Analysis]
114 Serota K, Bannerman G, Hong R, Buchman DZ. News Media Representations of Responsibility for Alcohol-Related Liver Disease Requiring Liver Transplantation. bioethics 2020;3:62-75. [DOI: 10.7202/1073781ar] [Reference Citation Analysis]
115 Amjad W, Alukal J, Doycheva I, Zhang T, Maheshwari A, Yoo H, Thuluvath PJ. A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis. Dig Dis Sci 2020;65:3726-33. [PMID: 32072435 DOI: 10.1007/s10620-020-06142-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
116 Jiang L, Lang S, Duan Y, Zhang X, Gao B, Chopyk J, Schwanemann LK, Ventura-Cots M, Bataller R, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross DL, Ho SB, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Kisseleva T, Brenner DA, Tu XM, Stärkel P, Pride D, Fouts DE, Schnabl B. Intestinal Virome in Patients With Alcoholic Hepatitis. Hepatology 2020;72:2182-96. [PMID: 32654263 DOI: 10.1002/hep.31459] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
117 Wu R, Pan S, Chen Y, Nakano Y, Li M, Balog S, Tsukamoto H. Fate and functional roles of Prominin 1+ cells in liver injury and cancer. Sci Rep 2020;10:19412. [PMID: 33173221 DOI: 10.1038/s41598-020-76458-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
118 Aizawa S, Brar G, Tsukamoto H. Cell Death and Liver Disease. Gut Liver 2020;14:20-9. [PMID: 30917630 DOI: 10.5009/gnl18486] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
119 Atkinson SR, Grove JI, Liebig S, Astbury S, Vergis N, Goldin R, Quaglia A, Bantel H, Guha IN, Thursz MR, Newcombe P, Strnad P, Aithal GP. In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers. Am J Gastroenterol 2020;115:1857-68. [PMID: 33156105 DOI: 10.14309/ajg.0000000000000912] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
120 Tana MM, McCoy D, Lee B, Patel R, Lin J, Ohliger MA. Texture features from computed tomography correlate with markers of severity in acute alcohol-associated hepatitis.Sci Rep. 2020;10:17980. [PMID: 33087739 DOI: 10.1038/s41598-020-74599-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
121 Shen NT, Bray J, Wahid NA, Raver M, Hutchison N, Brown RS Jr, Schackman BR. Evaluation of Alcohol Taxes as a Public Health Opportunity to Reduce Liver Transplant Listings for Alcohol-Related Liver Disease. Alcohol Clin Exp Res 2020;44:2307-15. [PMID: 32944958 DOI: 10.1111/acer.14454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Noureddin N, Yang JD, Alkhouri N, Noreen SM, Toll AE, Todo T, Ayoub W, Kuo A, Voidonikolas G, Kotler HG, Pelphrey MD, Durand BJ, Kosari K, Brennan TV, Kim I, Klein AS, Seki E, Nissen NN, Lu SC, Sundaram V, Noureddin M. Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 Analysis. Transplant Direct 2020;6:e612. [PMID: 33134488 DOI: 10.1097/TXD.0000000000001051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
123 Khatiwada P, Rodriguez JA, Reyes-Corcho A. Alcoholic Hepatitis: A Common Disease with Uncommon Presentation. Case Rep Gastroenterol 2020;14:448-52. [PMID: 32999647 DOI: 10.1159/000508426] [Reference Citation Analysis]
124 Akbari A, Sajadian H, Hosseini SH, Amiresmaili S, Instructor, Dept of Medical Surgical Nursing, School of Nursing and Midwifery Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences. Rafsanjan, Iran., MSc in Psychology, School of Nursing and Midwifery, Rafsanjan University of Medical Sciences, Rafsanjan, Iran., Assistant Prof, Dept of nursing Management, School of Nursing and Midwifery Geriatric Care Research Center, Rafsanjan, University of Medical Sciences, Rafsanjan, Iran., Assistant Prof., of Physiology, Dept of Basic Sciences, School of Medicine, Bam University of Medical Sciences, Bam, Iran. Prevalence of Urinary Tract Infection in Newborns with Prolonged Jaundice in Bam City, Iran (2015). JOHE 2020;9:225-230. [DOI: 10.52547/johe.9.4.225] [Reference Citation Analysis]
125 Tornai D, Szabo G. Emerging medical therapies for severe alcoholic hepatitis. Clin Mol Hepatol 2020;26:686-96. [PMID: 32981291 DOI: 10.3350/cmh.2020.0145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
126 Elitok B, Kişlalioğlu I, Ulusoy Y, Kilinç B. Investigation of the healing effects of Afyon Province hot spring waters on experimentally-induced fatty liver in mice. Veterinariâ segodnâ 2020. [DOI: 10.29326/2304-196x-2020-3-34-228-238] [Reference Citation Analysis]
127 Baig M, Walayat S, Dhillon S, Puli S. Efficacy of Granulocyte Colony Stimulating Factor in Severe Alcoholic Hepatitis: A Systematic Review and Meta-Analysis. Cureus 2020. [DOI: 10.7759/cureus.10474] [Reference Citation Analysis]
128 Lee DH, Choi YI, Bae JM, Chang MS, Joo SK, Jung YJ, Lee KL, Kim BG, Kim W. Prognostic Value of the Alcoholic Hepatitis Histologic Score in Korean Patients with Biopsy-Proven Alcoholic Hepatitis. Gut Liver 2020;14:636-43. [PMID: 32457277 DOI: 10.5009/gnl19203] [Reference Citation Analysis]
129 Xiang X, Hwang S, Feng D, Shah VH, Gao B. Interleukin-22 in alcoholic hepatitis and beyond. Hepatol Int 2020;14:667-76. [PMID: 32892258 DOI: 10.1007/s12072-020-10082-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
130 Palmer G, Singal AK. Refining criteria for liver biopsy in severe alcoholic hepatitis: Moving the field forward. United European Gastroenterol J 2020;8:993-4. [PMID: 32869737 DOI: 10.1177/2050640620957140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
131 Dubois M, Sciarra A, Trépo E, Marot A, Saldarriaga J, Moreno C, Sempoux C, Deltenre P. Histologic parameter score does not predict short-term survival in severe alcoholic hepatitis. United European Gastroenterol J 2020;8:1003-12. [PMID: 32778003 DOI: 10.1177/2050640620949737] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
132 Zhou R, Llorente C, Cao J, Gao B, Duan Y, Jiang L, Wang Y, Kumar V, Stärkel P, Bode L, Fan X, Schnabl B. Deficiency of Intestinal α1-2-Fucosylation Exacerbates Ethanol-Induced Liver Disease in Mice. Alcohol Clin Exp Res 2020;44:1842-51. [PMID: 32628772 DOI: 10.1111/acer.14405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
133 Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, Dreyer K, Yan X, Daley WL, Sanyal A, Chalasani N, Radaeva S, Yang L, Vargas H, Ibacache M, Gao B, Gores GJ, Malhi H, Kamath PS, Shah VH. An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis. Hepatology 2020;72:441-53. [PMID: 31774566 DOI: 10.1002/hep.31046] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]
134 Dasarathy S, Mitchell MC, Barton B, McClain CJ, Szabo G, Nagy LE, Radaeva S, McCullough AJ. Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis. Contemp Clin Trials 2020;96:106094. [PMID: 32739495 DOI: 10.1016/j.cct.2020.106094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
135 Yoshikawa E, Matsui-Yuasa I, Huang X, Kobayashi Y, Kojima-Yuasa A. Mallotus furetianus extract protects against ethanol-induced liver injury via the activation of the cAMP-PKA pathway. Food Sci Nutr 2020;8:3936-46. [PMID: 32724654 DOI: 10.1002/fsn3.1709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
136 Liu Y, Wang Z, Kong F, Teng L, Zheng X, Liu X, Wang D. Triterpenoids Extracted From Antrodia cinnamomea Mycelia Attenuate Acute Alcohol-Induced Liver Injury in C57BL/6 Mice via Suppression Inflammatory Response. Front Microbiol 2020;11:1113. [PMID: 32719658 DOI: 10.3389/fmicb.2020.01113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
137 Tan HK, Yates E, Lilly K, Dhanda AD. Oxidative stress in alcohol-related liver disease. WJH 2020;12:333-50. [DOI: 10.4254/wjh.v12.i7.333] [Reference Citation Analysis]
138 Tan HK, Yates E, Lilly K, Dhanda AD. Oxidative stress in alcohol-related liver disease. World J Hepatol 2020; 12(7): 332-349 [PMID: 32821333 DOI: 10.4254/wjh.v12.i7.332] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
139 Diesinger T, Buko V, Lautwein A, Dvorsky R, Belonovskaya E, Lukivskaya O, Naruta E, Kirko S, Andreev V, Buckert D, Bergler S, Renz C, Schneider E, Kuchenbauer F, Kumar M, Günes C, Büchele B, Simmet T, Müller-Enoch D, Wirth T, Haehner T. Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis. PLoS One 2020;15:e0235990. [PMID: 32701948 DOI: 10.1371/journal.pone.0235990] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
140 Furuya S, Cichocki JA, Konganti K, Dreval K, Uehara T, Katou Y, Fukushima H, Kono H, Pogribny IP, Argemi J, Bataller R, Rusyn I. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis. Toxicol Sci 2019;170:427-37. [PMID: 30517762 DOI: 10.1093/toxsci/kfy292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
141 Velarde-ruiz Velasco J, Higuera-de la Tijera M, Castro-narro G, Zamarripa-dorsey F, Abdo-francis J, Aiza Haddad I, Aldana Ledesma J, Bielsa-fernández M, Cerda-reyes E, Cisneros-garza L, Contreras-omaña R, Reyes-dorantes A, Fernández-pérez N, García-jiménez E, Icaza-chávez M, Kershenobich-stalnikowitz D, Lira-pedrín M, Moreno-alcántar R, Pérez-hernández J, Ramos-gómez M, Rizo-robles M, Solana-sentíes S, Torre-delgadillo A. Consenso Mexicano de hepatitis alcohólica. Revista de Gastroenterología de México 2020;85:332-353. [DOI: 10.1016/j.rgmx.2020.04.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Arab JP, Cabrera D, Sehrawat TS, Jalan-Sakrikar N, Verma VK, Simonetto D, Cao S, Yaqoob U, Leon J, Freire M, Vargas JI, De Assuncao TM, Kwon JH, Guo Y, Kostallari E, Cai Q, Kisseleva T, Oh Y, Arrese M, Huebert RC, Shah VH. Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12. J Hepatol 2020;73:149-60. [PMID: 32087348 DOI: 10.1016/j.jhep.2020.02.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
143 Velarde-ruiz Velasco J, Higuera-de la Tijera M, Castro-narro G, Zamarripa-dorsey F, Abdo-francis J, Haddad IA, Aldana Ledesma J, Bielsa-fernández M, Cerda-reyes E, Cisneros-garza L, Contreras-omaña R, Reyes-dorantes A, Fernández-pérez N, García-jiménez E, Icaza-chávez M, Kershenobich-stalnikowitz D, Lira-pedrín M, Moreno-alcántar R, Pérez-hernández J, Ramos-gómez M, Rizo-robles M, Solana-sentíes S, Torre-delgadillo A. The Mexican consensus on alcoholic hepatitis. Revista de Gastroenterología de México (English Edition) 2020;85:332-353. [DOI: 10.1016/j.rgmxen.2020.04.004] [Reference Citation Analysis]
144 Kim S, Oh H, Cha Y, Kim M, Kim H. Evaluation of hepatic injury in acute carbon monoxide-poisoned patients in emergency department. Hum Exp Toxicol 2020;39:883-889. [DOI: 10.1177/0960327120909521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Yu H, Liu P, Zhu D, Yin J, Yang Q, Huang Y, Chen Y, Zhang C, Gao Y. Chrysophanic acid shifts the differentiation tendency of BMSCs to prevent alcohol-induced osteonecrosis of the femoral head. Cell Prolif 2020;53:e12871. [PMID: 32597546 DOI: 10.1111/cpr.12871] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
146 Shasthry SM. Fecal microbiota transplantation in alcohol related liver diseases. Clin Mol Hepatol 2020;26:294-301. [PMID: 32570299 DOI: 10.3350/cmh.2020.0057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
147 Gao B, Duan Y, Lang S, Barupal D, Wu TC, Valdiviez L, Roberts B, Choy YY, Shen T, Byram G, Zhang Y, Fan S, Wancewicz B, Shao Y, Vervier K, Wang Y, Zhou R, Jiang L, Nath S, Loomba R, Abraldes JG, Bataller R, Tu XM, Stärkel P, Lawley TD, Fiehn O, Schnabl B. Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co-Metabolism in Patients With Alcoholic Hepatitis. Hepatol Commun 2020;4:1168-82. [PMID: 32766476 DOI: 10.1002/hep4.1537] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
148 Marot A, Singal AK, Moreno C, Deltenre P. Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials. JHEP Rep 2020;2:100139. [PMID: 32775975 DOI: 10.1016/j.jhepr.2020.100139] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
149 Kamran U, Towey J, Khanna A, Chauhan A, Rajoriya N, Holt A. Nutrition in alcohol-related liver disease: Physiopathology and management. World J Gastroenterol 2020; 26(22): 2916-2930 [PMID: 32587439 DOI: 10.3748/wjg.v26.i22.2916] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
150 Artru F, Bou Saleh M, Maggiotto F, Lassailly G, Ningarhari M, Demaret J, Ntandja-Wandji LC, Pais de Barros JP, Labreuche J, Drumez E, Helou DG, Dharancy S, Gantier E, Périanin A, Chollet-Martin S, Bataller R, Mathurin P, Dubuquoy L, Louvet A. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis. J Hepatol 2020;72:1052-61. [PMID: 31953139 DOI: 10.1016/j.jhep.2019.12.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
151 Mellinger JL, Stine JG. Early Liver Transplantation for Severe Alcoholic Hepatitis. Dig Dis Sci 2020;65:1608-14. [PMID: 32107678 DOI: 10.1007/s10620-020-06159-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
152 Parker R, Schmidt MS, Cain O, Gunson B, Brenner C. Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol-Related Liver Disease. Hepatol Commun 2020;4:1183-92. [PMID: 32766477 DOI: 10.1002/hep4.1530] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
153 Qi W, Wang B, Yang M, Zhu L, Hu S, Sun H. The implementation of drug reposition for alcoholic hepatitis based on a sub-pathway integration strategy. Ann Transl Med 2020;8:208. [PMID: 32309355 DOI: 10.21037/atm.2020.01.36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
154 Glahn A, Proskynitopoulos PJ, Bleich S, Hillemacher T. Pharmacotherapeutic management of acute alcohol withdrawal syndrome in critically Ill patients. Expert Opin Pharmacother 2020;21:1083-92. [PMID: 32281894 DOI: 10.1080/14656566.2020.1746271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
155 Gitto S, Aspite S, Golfieri L, Caputo F, Vizzutti F, Grandi S, Patussi V, Marra F. Alcohol use disorder and liver transplant: new perspectives and critical issues. Korean J Intern Med 2020;35:797-810. [PMID: 32241080 DOI: 10.3904/kjim.2019.409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
156 Heck E, Gruslin K, Corder V, Petroll WM, Urban J. Positive toxicology and reactive serology in tissue donors: a retrospective study over a 3-year period. Cell Tissue Bank 2020;21:427-31. [PMID: 32246221 DOI: 10.1007/s10561-020-09827-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
157 Lang S, Demir M, Duan Y, Martin A, Schnabl B. Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis. Liver Int 2020;40:860-5. [PMID: 31943701 DOI: 10.1111/liv.14377] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
158 Parker R, Schmidt MS, Cain O, Gunson B, Brenner C. The NAD Metabolome is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol-related Liver Disease.. [DOI: 10.1101/2020.03.28.013581] [Reference Citation Analysis]
159 Wang ZD, Zhang Y, Dai YD, Ren K, Han C, Wang HX, Yi SQ. Tamarix chinensis Lour inhibits chronic ethanol-induced liver injury in mice. World J Gastroenterol 2020; 26(12): 1286-1297 [PMID: 32256017 DOI: 10.3748/wjg.v26.i12.1286] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Atkinson SR, Hamesch K, Spivak I, Guldiken N, Cabezas J, Argemi J, Theurl I, Zoller H, Cao S, Mathurin P, Shah VH, Trautwein C, Bataller R, Thursz MR, Strnad P. Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis. Am J Gastroenterol 2020;115:398-405. [PMID: 31985531 DOI: 10.14309/ajg.0000000000000492] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
161 Forrest E. Alcoholic liver disease. Oxford Textbook of Medicine 2020. [DOI: 10.1093/med/9780198746690.003.0327] [Reference Citation Analysis]
162 Deltenre P, Trépo E, Fujiwara N, Goossens N, Marot A, Dubois M, Spahr L, Henrion J, Moreno C, Hoshida Y. Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis. Liver Int 2020;40:565-70. [PMID: 31568650 DOI: 10.1111/liv.14265] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
163 Palma E, Riva A, Moreno C, Odena G, Mudan S, Manyakin N, Miquel R, Degré D, Trepo E, Sancho-Bru P, Altamirano J, Caballeria J, Zamalloa A, Menon K, Heaton N, Williams R, Bataller R, Chokshi S. Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver Disease. Alcohol Clin Exp Res 2020;44:856-65. [PMID: 32020641 DOI: 10.1111/acer.14299] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
164 Kitajima T, Moonka D, Yeddula S, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Nagai S. Liver transplant waitlist outcomes in alcoholic hepatitis compared with other liver diseases: An analysis of UNOS registry. Clin Transplant 2020;34:e13837. [PMID: 32073688 DOI: 10.1111/ctr.13837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
165 Gao B, Xiang X, Leggio L, Koob GF. Alcoholic Liver Disease. The Liver 2020. [DOI: 10.1002/9781119436812.ch53] [Reference Citation Analysis]
166 Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States. JAMA Intern Med. 2019;179:340-348. [PMID: 30667468 DOI: 10.1001/jamainternmed.2018.6536] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 32.0] [Reference Citation Analysis]
167 Rachakonda V, Bataller R, Duarte-Rojo A. Recent advances in alcoholic hepatitis. F1000Res 2020;9:F1000 Faculty Rev-97. [PMID: 32089834 DOI: 10.12688/f1000research.20394.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
168 Wan YM, Li ZQ, Zhou Q, Liu C, Wang MJ, Wu HX, Mu YZ, He YF, Zhang Y, Wu XN, Li YH, Xu ZY, Wu HM, Xu Y, Yang JH, Wang XF. Mesenchymal stem cells alleviate liver injury induced by chronic-binge ethanol feeding in mice via release of TSG6 and suppression of STAT3 activation. Stem Cell Res Ther 2020;11:24. [PMID: 31931878 DOI: 10.1186/s13287-019-1547-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
169 Adesina E, Oyero O, Okorie N, Ben-enukora C, Adeyeye B. Risk Communication for Viral Hepatitis Management Among Migrants. Handbook of Research on the Global Impact of Media on Migration Issues 2020. [DOI: 10.4018/978-1-7998-0210-5.ch014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
170 Mellinger JL, Fontana RJ. The ICU Management of Alcoholic Liver Disease. Evidence-Based Critical Care 2020. [DOI: 10.1007/978-3-030-26710-0_75] [Reference Citation Analysis]
171 Ahn JC, Shah VH. Alcoholic Hepatitis and Alcohol-Related Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_14] [Reference Citation Analysis]
172 Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020;71:306-33. [PMID: 31314133 DOI: 10.1002/hep.30866] [Cited by in Crossref: 262] [Cited by in F6Publishing: 209] [Article Influence: 87.3] [Reference Citation Analysis]
173 Lackner C. Alkoholische Lebererkrankungen (ALD). Pathologie 2020. [DOI: 10.1007/978-3-642-04557-8_6] [Reference Citation Analysis]
174 Bloom PP, Mojtahed A, Bethea ED, Knooihuizen SA, Choi J, Dienstag JL, Chung RT, Hur C. Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes. Dig Dis Sci 2020;65:312-21. [PMID: 31363954 DOI: 10.1007/s10620-019-05721-4] [Reference Citation Analysis]
175 Pedersen MR, Tujios SR. Acute on Chronic Liver Failure. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_11] [Reference Citation Analysis]
176 Ventura-cots M, Rachakonda V, Bataller R. Alcoholic Liver Disease, Management of. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65788-4] [Reference Citation Analysis]
177 Testino G, Vignoli T, Patussi V, Scafato E, Caputo F; SIA board (Appendix A) and the external expert supervisors (Appendix B). Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA). Dig Liver Dis 2020;52:21-32. [PMID: 31757596 DOI: 10.1016/j.dld.2019.09.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
178 Bataller R, Cabezas J, Aller R, Ventura-cots M, Abad J, Albillos A, Altamirano J, Arias-loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández-rodríguez C, Gallego R, García-cortes M, García-monzón C, Genescà J, Ginés P, Hernandez-guerra M, Jorquera F, Lligoña A, Molina E, Pareja MJ, Planas R, Tomé S, Salmerón J, Romero-gómez M. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterología y Hepatología (English Edition) 2019;42:657-676. [DOI: 10.1016/j.gastre.2019.09.003] [Reference Citation Analysis]
179 Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, Altamirano J, Arias-Loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández Rodríguez C, Gallego R, García-Cortes M, García-Monzón C, Genescà J, Ginés P, Hernandez-Guerra M, Jorquera F, Lligoña A, Molina E, Pareja MJ, Planas R, Tomé S, Salmerón J, Romero-Gómez M. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterol Hepatol 2019;42:657-76. [PMID: 31771785 DOI: 10.1016/j.gastrohep.2019.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
180 Furuya S, Argemi J, Uehara T, Katou Y, Fouts DE, Schnabl B, Dubuquoy L, Belorkar A, Vadigepalli R, Kono H, Bataller R, Rusyn I. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis. Alcohol Clin Exp Res 2020;44:87-101. [PMID: 31710124 DOI: 10.1111/acer.14234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
181 Osadchuk MA, Mironova ED. Non-viral liver diseases: pathogenetic approaches to therapy. Medicinskij alfavit 2019;3:30-36. [DOI: 10.33667/2078-5631-2019-2-20(395)-30-36] [Reference Citation Analysis]
182 Huang H, Lin Z, Zeng Y, Lin X, Zhang Y. Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model.Exp Ther Med. 2019;18:4733-4739. [PMID: 31777560 DOI: 10.3892/etm.2019.8123] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
183 Singal AK, Kamath PS. Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease. Transl Gastroenterol Hepatol 2019;4:74. [PMID: 31728431 DOI: 10.21037/tgh.2019.09.11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
184 Srinivasan MP, Bhopale KK, Amer SM, Wan J, Kaphalia L, Ansari GS, Kaphalia BS. Linking Dysregulated AMPK Signaling and ER Stress in Ethanol-Induced Liver Injury in Hepatic Alcohol Dehydrogenase Deficient Deer Mice. Biomolecules 2019;9:E560. [PMID: 31581705 DOI: 10.3390/biom9100560] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
185 Saha B, Tornai D, Kodys K, Adejumo A, Lowe P, McClain C, Mitchell M, McCullough A, Dasarathy S, Kroll-Desrosiers A, Barton B, Radaeva S, Szabo G. Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis. Hepatology 2019;70:1134-49. [PMID: 30891779 DOI: 10.1002/hep.30617] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 11.3] [Reference Citation Analysis]
186 Luo P, Wang F, Wong NK, Lv Y, Li X, Li M, Tipoe GL, So KF, Xu A, Chen S, Xiao J, Wang H. Divergent Roles of Kupffer Cell TLR2/3 Signaling in Alcoholic Liver Disease and the Protective Role of EGCG. Cell Mol Gastroenterol Hepatol 2020;9:145-60. [PMID: 31562937 DOI: 10.1016/j.jcmgh.2019.09.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
187 Petrasek J, Erhartova D, Levine B. Protective Effect of SMAD-Specific E3 Ubiquitin Protein Ligase 1 in Alcoholic Steatohepatitis in Mice. Hepatol Commun 2019;3:1450-8. [PMID: 31701069 DOI: 10.1002/hep4.1427] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
188 Daniel KE, Lucey MR. Editorial: moderate alcoholic hepatitis-hiding in plain sight. Aliment Pharmacol Ther 2019;50:608-9. [PMID: 31414539 DOI: 10.1111/apt.15436] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
189 Shasthry SM, Sharma MK, Shasthry V, Pande A, Sarin SK. Efficacy of Granulocyte Colony-stimulating Factor in the Management of Steroid-Nonresponsive Severe Alcoholic Hepatitis: A Double-Blind Randomized Controlled Trial. Hepatology 2019;70:802-11. [PMID: 30664267 DOI: 10.1002/hep.30516] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 10.5] [Reference Citation Analysis]
190 Bennett K, Enki DG, Thursz M, Cramp ME, Dhanda AD. Systematic review with meta-analysis: high mortality in patients with non-severe alcoholic hepatitis. Aliment Pharmacol Ther 2019;50:249-57. [PMID: 31231848 DOI: 10.1111/apt.15376] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
191 Hao X, Zhang D, Huang Z. Emerging Research Trends and Development of Alcoholic Liver Disease Based on Bibliometrics and Visualizaed Analysis. 2019 10th International Conference on Information Technology in Medicine and Education (ITME) 2019. [DOI: 10.1109/itme.2019.00038] [Reference Citation Analysis]
192 Li JS, Fan LY, Yuan MD, Xing MY. Salidroside Inhibits Lipopolysaccharide-ethanol-induced Activation of Proinflammatory Macrophages via Notch Signaling Pathway. Curr Med Sci 2019;39:526-33. [PMID: 31346986 DOI: 10.1007/s11596-019-2069-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
193 Wong VW, Singal AK. Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis. Transl Gastroenterol Hepatol. 2019;4:53. [PMID: 31463412 DOI: 10.21037/tgh.2019.06.06] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
194 Parker R, Kim SJ, Im GY, Nahas J, Dhesi B, Vergis N, Sinha A, Ghezzi A, Rink MR, McCune A, Aithal GP, Newsome PN, Weston CJ, Holt A, Gao B. Obesity in acute alcoholic hepatitis increases morbidity and mortality. EBioMedicine 2019;45:511-8. [PMID: 31278069 DOI: 10.1016/j.ebiom.2019.03.046] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
195 Suzuki Y, Kakisaka K, Suzuki A, Takahara T, Sasaki T, Sato T, Yonezawa T, Nitta H, Takikawa Y. A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients. Hepatol Res 2019;49:758-64. [PMID: 30901152 DOI: 10.1111/hepr.13334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
196 Shi X, Jiang X, Yuan B, Liu T, Tang Y, Che Y, Shi Y, Ai Q. LINC01093 Upregulation Protects against Alcoholic Hepatitis through Inhibition of NF-κB Signaling Pathway. Mol Ther Nucleic Acids 2019;17:791-803. [PMID: 31450097 DOI: 10.1016/j.omtn.2019.06.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
197 Liang S, Zhong Z, Kim SY, Uchiyama R, Roh YS, Matsushita H, Gottlieb RA, Seki E. Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria. J Biol Chem. 2019;294:12359-12369. [PMID: 31235522 DOI: 10.1074/jbc.ra119.007409] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
198 Shipley LC, Kodali S, Singal AK. Recent updates on alcoholic hepatitis. Dig Liver Dis 2019;51:761-8. [PMID: 31010745 DOI: 10.1016/j.dld.2019.03.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
199 Choi W, Kim M, Jeong W. Functions of hepatic non-parenchymal cells in alcoholic liver disease. Liver Research 2019;3:80-7. [DOI: 10.1016/j.livres.2019.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Ben-enukora C, Amodu L, Okorie N. Health Communication and Hepatitis Health Management: A Study on the Awareness and Behavioural Practices in Nigeria. Journal of Health Management 2019;21:313-25. [DOI: 10.1177/0972063419835128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
201 Lee BP, Terrault NA. Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transplant 2018;23:229-36. [PMID: 29389821 DOI: 10.1097/MOT.0000000000000507] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
202 Huo X, Sun X, Cao Z, Qiao J, Yang S, Meng X, Zhao Y. Optimal ratio of 18α- and 18β-glycyrrhizic acid for preventing alcoholic hepatitis in rats. Exp Ther Med 2019;18:172-8. [PMID: 31258651 DOI: 10.3892/etm.2019.7572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
203 Gupta H, Youn GS, Shin MJ, Suk KT. Role of Gut Microbiota in Hepatocarcinogenesis. Microorganisms. 2019;7:pii: E121. [PMID: 31060311 DOI: 10.3390/microorganisms7050121] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 14.8] [Reference Citation Analysis]
204 Szabo G, Kamath PS, Shah VH, Thursz M, Mathurin P; EASL-AASLD Joint Meeting. Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study. Hepatology 2019;69:2271-83. [PMID: 30645002 DOI: 10.1002/hep.30369] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
205 Arab JP, Roblero JP, Altamirano J, Bessone F, Chaves Araujo R, Higuera-De la Tijera F, Restrepo JC, Torre A, Urzua A, Simonetto DA, Abraldes JG, Méndez-Sánchez N, Contreras F, Lucey MR, Shah VH, Cortez-Pinto H, Bataller R. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol 2019;18:518-35. [PMID: 31053546 DOI: 10.1016/j.aohep.2019.04.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
206 Lee JY, Cho Y, Hong MH, Kim J, Lee DH, Jung YJ, Kim BG, Lee KL, Kim W. Incidence, inhospital mortality, and readmission among patients with alcoholic hepatitis in Korea: A nationwide study. J Gastroenterol Hepatol 2019;34:747-54. [PMID: 30345539 DOI: 10.1111/jgh.14513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
207 Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol 2019;16:235-46. [PMID: 30643227 DOI: 10.1038/s41575-018-0099-1] [Cited by in Crossref: 256] [Cited by in F6Publishing: 248] [Article Influence: 64.0] [Reference Citation Analysis]
208 Vonghia L, Van Herck MA, Weyler J, Francque S. Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease. Front Immunol 2019;10:563. [PMID: 30972062 DOI: 10.3389/fimmu.2019.00563] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
209 Ambade A, Lowe P, Kodys K, Catalano D, Gyongyosi B, Cho Y, Iracheta-Vellve A, Adejumo A, Saha B, Calenda C, Mehta J, Lefebvre E, Vig P, Szabo G. Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice. Hepatology 2019;69:1105-21. [PMID: 30179264 DOI: 10.1002/hep.30249] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 21.3] [Reference Citation Analysis]
210 Tolefree JA, Garcia AJ, Farrell J, Meadows V, Kennedy L, Hargrove L, Demieville J, Francis N, Mirabel J, Francis H. Alcoholic liver disease and mast cells: What's your gut got to do with it? Liver Research 2019;3:46-54. [DOI: 10.1016/j.livres.2019.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
211 Thursz M, Kamath PS, Mathurin P, Szabo G, Shah VH. Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study. J Hepatol 2019;70:521-30. [PMID: 30658117 DOI: 10.1016/j.jhep.2018.10.041] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 13.0] [Reference Citation Analysis]
212 Ventura-cots M, Ndugga N, Bataller R. Alcoholic Liver Disease. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch34] [Reference Citation Analysis]
213 Laitakari A, Ollonen T, Kietzmann T, Walkinshaw G, Mennerich D, Izzi V, Haapasaari KM, Myllyharju J, Serpi R, Dimova EY, Koivunen P. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease. Redox Biol 2019;22:101145. [PMID: 30802717 DOI: 10.1016/j.redox.2019.101145] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
214 Park MS, Hong S, Lim YL, Kang SH, Baik SK, Kim MY. Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study. Gut Liver 2018;12:555-61. [PMID: 29699059 DOI: 10.5009/gnl17342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
215 Im GY. Acute Alcoholic Hepatitis. Clin Liver Dis 2019;23:81-98. [PMID: 30454835 DOI: 10.1016/j.cld.2018.09.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
216 Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol 2019;70:294-304. [PMID: 30658730 DOI: 10.1016/j.jhep.2018.12.003] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 26.0] [Reference Citation Analysis]
217 Axley PD, Richardson CT, Singal AK. Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease. Clin Liver Dis 2019;23:39-50. [PMID: 30454831 DOI: 10.1016/j.cld.2018.09.011] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 19.0] [Reference Citation Analysis]
218 Mathurin P, Thursz M. Endpoints and patient stratification in clinical trials for alcoholic hepatitis. J Hepatol 2019;70:314-8. [PMID: 30658732 DOI: 10.1016/j.jhep.2018.11.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
219 Singal AK, Shah VH. Current trials and novel therapeutic targets for alcoholic hepatitis. J Hepatol 2019;70:305-13. [PMID: 30658731 DOI: 10.1016/j.jhep.2018.10.026] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis]
220 Tasdogan BE, Akosman S, Gurakar M, Simsek C, Gurakar A. Update on Liver Transplantation: What is New Recently? Euroasian J Hepatogastroenterol 2019;9:34-9. [PMID: 31988865 DOI: 10.5005/jp-journals-10018-1293] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
221 Meeks TW, Bekman NM, Lanouette NM, Yung KA, Vienna RP. Alcohol and Alcohol Use Disorder. Veteran Psychiatry in the US 2019. [DOI: 10.1007/978-3-030-05384-0_9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
222 Michelena J, Alonso C, Martínez-Arranz I, Altamirano J, Mayo R, Sancho-Bru P, Bataller R, Ginès P, Castro A, Caballería J. Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis. Ann Hepatol 2019;18:144-54. [PMID: 31113584 DOI: 10.5604/01.3001.0012.7906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
223 El-din El-sayed El-sisi A, Salim Sokar S, Zakaria Mohamed D. Current Therapeutic Strategies for Alcoholic Liver Disease. Dietary Interventions in Liver Disease 2019. [DOI: 10.1016/b978-0-12-814466-4.00002-1] [Reference Citation Analysis]
224 Cho Y, Park YS, Kim HY, Kim W, Lee HJ, Kim DJ. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial. Trials 2018;19:696. [PMID: 30577864 DOI: 10.1186/s13063-018-3092-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
225 Singh V, Keisham A, Bhalla A, Sharma N, Agarwal R, Sharma R, Singh A. Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2018;16:1650-1656.e2. [PMID: 29391265 DOI: 10.1016/j.cgh.2018.01.040] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
226 Mansouri A, Gattolliat CH, Asselah T. Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases. Gastroenterology 2018;155:629-47. [PMID: 30012333 DOI: 10.1053/j.gastro.2018.06.083] [Cited by in Crossref: 299] [Cited by in F6Publishing: 303] [Article Influence: 59.8] [Reference Citation Analysis]
227 Trieu JA, Bilal M, Lewis B, Gou E, Sonstein L, Parupudi S. Adherence to Appropriate Nutrition in Acute Alcoholic Hepatitis is Low. Ann Hepatol 2018;17:752-5. [PMID: 30145576 DOI: 10.5604/01.3001.0012.3132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
228 Patel SA, Sharma S, Rahman A, Daftary V, Shah P. PHES: RELIABLE, BED SIDE DIAGNOSTIC TOOL IN IDENTIFICATION OF MINIMAL HEPATIC ENCEPHALOPATHY. jebmh 2018;5:2529-2535. [DOI: 10.18410/jebmh/2018/522] [Reference Citation Analysis]
229 Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4:16. [PMID: 30115921 DOI: 10.1038/s41572-018-0014-7] [Cited by in Crossref: 348] [Cited by in F6Publishing: 382] [Article Influence: 69.6] [Reference Citation Analysis]
230 Muga R, Sanvisens A, Jarrin I, Fuster D, Bolao F, Tor J, Muñoz A. Hepatitis C infection substantially reduces survival of alcohol-dependent patients. Clin Epidemiol 2018;10:897-905. [PMID: 30123002 DOI: 10.2147/CLEP.S162308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
231 Yin S, Feng D. WITHDRAWN: IL-22 in liver inflammation, injury and repair. Liver Research 2018. [DOI: 10.1016/j.livres.2017.10.001] [Reference Citation Analysis]
232 Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, Ghobrial RM, Dodge JL, Li Z, Terrault NA. Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis. Gastroenterology 2018;155:422-430.e1. [PMID: 29655837 DOI: 10.1053/j.gastro.2018.04.009] [Cited by in Crossref: 180] [Cited by in F6Publishing: 187] [Article Influence: 36.0] [Reference Citation Analysis]
233 Rolas L, Boussif A, Weiss E, Lettéron P, Haddad O, El-Benna J, Rautou PE, Moreau R, Périanin A. NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7/8 activation. Gut 2018;67:1505-16. [PMID: 28601846 DOI: 10.1136/gutjnl-2016-313443] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
234 Singal AK, Louvet A, Shah VH, Kamath PS. Grand Rounds: Alcoholic Hepatitis. J Hepatol 2018;69:534-43. [PMID: 29753761 DOI: 10.1016/j.jhep.2018.05.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
235 Spahr L, Goossens N, Furrer F, Dupuis M, Vijgen S, Elkrief L, Giostra E, Rubbia-Brandt L, Frossard JL. A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis. Eur J Gastroenterol Hepatol 2018;30:967-74. [PMID: 29727387 DOI: 10.1097/MEG.0000000000001148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
236 Singal AK, Bailey SM. Cellular Abnormalities and Emerging Biomarkers in Alcohol-Associated Liver Disease. Gene Expr 2018;19:49-60. [PMID: 30086817 DOI: 10.3727/105221618X15325235888914] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
237 Marroni CA, Fleck Jr AM, Fernandes SA, Galant LH, Mucenic M, de Mattos Meine MH, Mariante-Neto G, Brandão ABM. Liver transplantation and alcoholic liver disease: History, controversies, and considerations. World J Gastroenterol 2018; 24(26): 2785-2805 [PMID: 30018475 DOI: 10.3748/wjg.v24.i26.2785] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 68] [Article Influence: 13.6] [Reference Citation Analysis]
238 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol 2018;69:154-81. [PMID: 29628280 DOI: 10.1016/j.jhep.2018.03.018] [Cited by in Crossref: 352] [Cited by in F6Publishing: 333] [Article Influence: 70.4] [Reference Citation Analysis]
239 Butler DC, Lewin DN, Batalis NI. Differential Diagnosis of Hepatic Necrosis Encountered at Autopsy. Acad Forensic Pathol 2018;8:256-95. [PMID: 31240042 DOI: 10.1177/1925362118782056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
240 Parker R, Neuberger JM. Alcohol, Diet and Drug Use Preceding Alcoholic Hepatitis. Dig Dis 2018;36:298-305. [PMID: 29852499 DOI: 10.1159/000487392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
241 Yeoh SF, Lee TJ, Chew KL, Lin S, Yeo D, Setia S. Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. Infect Drug Resist. 2018;11:805-819. [PMID: 29881298 DOI: 10.2147/idr.s165676] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
242 Wang S, Wang H, Ding WX. Pyroptosis, A novel player for alcoholic hepatitis? Hepatology 2018;67:1660-2. [PMID: 29222919 DOI: 10.1002/hep.29725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
243 Glavind E, Aagaard NK, Gronbaek H, Orntoft NW, Vilstrup H, Thomsen KL. Time course of compromised urea synthesis in patients with alcoholic hepatitis. Scand J Gastroenterol 2018;53:592-7. [PMID: 29113530 DOI: 10.1080/00365521.2017.1399163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
244 Khanova E, Wu R, Wang W, Yan R, Chen Y, French SW, Llorente C, Pan SQ, Yang Q, Li Y, Lazaro R, Ansong C, Smith RD, Bataller R, Morgan T, Schnabl B, Tsukamoto H. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 2018;67:1737-53. [PMID: 29108122 DOI: 10.1002/hep.29645] [Cited by in Crossref: 122] [Cited by in F6Publishing: 118] [Article Influence: 24.4] [Reference Citation Analysis]
245 Santos SGRD, Mattos AA, Guimarães MM, Boger BS, Coral GP. Alcohol Consumption Influences Clinical Outcome in Patients Admitted to a Referral Center for Liver Disease. Ann Hepatol 2018;17:470-5. [PMID: 29735785 DOI: 10.5604/01.3001.0011.7391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
246 Cho YE, Song BJ, Akbar M, Baek MC. Extracellular vesicles as potential biomarkers for alcohol- and drug-induced liver injury and their therapeutic applications. Pharmacol Ther. 2018;187:180-194. [PMID: 29621595 DOI: 10.1016/j.pharmthera.2018.03.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
247 Puri P, Liangpunsakul S, Christensen JE, Shah VH, Kamath PS, Gores GJ, Walker S, Comerford M, Katz B, Borst A, Yu Q, Kumar DP, Mirshahi F, Radaeva S, Chalasani NP, Crabb DW, Sanyal AJ; TREAT Consortium. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis. Hepatology 2018;67:1284-302. [PMID: 29083504 DOI: 10.1002/hep.29623] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 16.4] [Reference Citation Analysis]
248 Thompson J, Jones N, Al-Khafaji A, Malik S, Reich D, Munoz S, MacNicholas R, Hassanein T, Teperman L, Stein L, Duarte-Rojo A, Malik R, Adhami T, Asrani S, Shah N, Gaglio P, Duddempudi A, Borg B, Jalan R, Brown R, Patton H, Satoskar R, Rossi S, Parikh A, ElSharkawy A, Mantry P, Sher L, Wolf D, Hart M, Landis C, Wigg A, Habib S, McCaughan G, Colquhoun S, Henry A, Bedard P, Landeen L, Millis M, Ashley R, Frank W, Henry A, Stange J, Subramanian R; VTI-208 Study Group. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl 2018;24:380-93. [PMID: 29171941 DOI: 10.1002/lt.24986] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 14.2] [Reference Citation Analysis]
249 Nahas J, Im GY. Early liver transplantation for severe alcoholic hepatitis. Clin Liver Dis (Hoboken) 2018;11:69-72. [PMID: 30992792 DOI: 10.1002/cld.693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
250 Trépo E, Goossens N, Fujiwara N, Song WM, Colaprico A, Marot A, Spahr L, Demetter P, Sempoux C, Im GY, Saldarriaga J, Gustot T, Devière J, Thung SN, Minsart C, Sersté T, Bontempi G, Abdelrahman K, Henrion J, Degré D, Lucidi V, Rubbia-Brandt L, Nair VD, Moreno C, Deltenre P, Hoshida Y, Franchimont D. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis. Gastroenterology 2018;154:965-75. [PMID: 29158192 DOI: 10.1053/j.gastro.2017.10.048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
251 Daswani R, Kumar A, Anikhindi SA, Sharma P, Singla V, Bansal N, Arora A. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India. Indian J Gastroenterol 2018;37:141-52. [PMID: 29704174 DOI: 10.1007/s12664-018-0842-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
252 Svistunov AA, Osadchuk MA, Kireeva NV, Osadchuk MM. Optimizing therapy of liver diseases not associated with viral infection. Terapevticheskii arkhiv 2018;90:94-99. [DOI: 10.26442/terarkh2018902105-111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
253 Hughes E, Hopkins LJ, Parker R. Survival from alcoholic hepatitis has not improved over time. PLoS One 2018;13:e0192393. [PMID: 29444123 DOI: 10.1371/journal.pone.0192393] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
254 Karoly HC, Bidwell LC, Mueller RL, Hutchison KE. Investigating the Relationships Between Alcohol Consumption, Cannabis Use, and Circulating Cytokines: A Preliminary Analysis. Alcohol Clin Exp Res 2018;42:531-9. [PMID: 29286537 DOI: 10.1111/acer.13592] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
255 Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol 2018;113:175-94. [PMID: 29336434 DOI: 10.1038/ajg.2017.469] [Cited by in Crossref: 344] [Cited by in F6Publishing: 332] [Article Influence: 68.8] [Reference Citation Analysis]
256 Ghosh Dastidar S, Warner JB, Warner DR, McClain CJ, Kirpich IA. Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration. Biomolecules 2018;8:E3. [PMID: 29342874 DOI: 10.3390/biom8010003] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 12.4] [Reference Citation Analysis]
257 Daswani R, Kumar A, Sharma P, Singla V, Bansal N, Arora A. Role of liver transplantation in severe alcoholic hepatitis. Clin Mol Hepatol 2018;24:43-50. [PMID: 29316778 DOI: 10.3350/cmh.2017.0027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
258 Gao B, Zakhari S. Epidemiology and Pathogenesis of Alcoholic Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00022-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
259 Singal AK, Shah VH. Prevention and Management of Alcoholic Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00024-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
260 Habib S, Shaikh OS. Approach to Jaundice and Abnormal Liver Function Test Results. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00007-0] [Reference Citation Analysis]
261 Sud V, van der Windt D, Tsung A. Toll-Like Receptors, PAMPs, and DAMPs in Hepatotoxicity. Comprehensive Toxicology 2018. [DOI: 10.1016/b978-0-12-801238-3.64266-6] [Reference Citation Analysis]
262 Chien YW, Peng HC, Chen YL, Pai MH, Wang HY, Chuang HL, Yang SC. Different Dietary Proportions of Fish Oil Regulate Inflammatory Factors but Do Not Change Intestinal Tight Junction ZO-1 Expression in Ethanol-Fed Rats. Mediators Inflamm 2017;2017:5801768. [PMID: 29386752 DOI: 10.1155/2017/5801768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
263 Choi Y, Abdelmegeed MA, Song BJ. Preventive effects of indole-3-carbinol against alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms: Role of gut-liver-adipose tissue axis. J Nutr Biochem 2018;55:12-25. [PMID: 29331880 DOI: 10.1016/j.jnutbio.2017.11.011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
264 Roth NC, Saberi B, Macklin J, Kanel G, French SW, Govindarajan S, Buzzanco AS, Stolz AA, Donovan JA, Kaplowitz N. Prediction of histologic alcoholic hepatitis based on clinical presentation limits the need for liver biopsy. Hepatol Commun 2017;1:1070-84. [PMID: 29404443 DOI: 10.1002/hep4.1119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
265 Ceulemans A, Verhulst S, Van Haele M, Govaere O, Ventura JJ, van Grunsven LA, Roskams T. RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers. Cell Death Dis 2017;8:e3164. [PMID: 29095436 DOI: 10.1038/cddis.2017.543] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
266 You M, Zhou Z, Daniels M, Jogasuria A. Endocrine Adiponectin-FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury. Gene Expr 2018;18:103-13. [PMID: 29096734 DOI: 10.3727/105221617X15093738210295] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
267 Louvet A, Labreuche J, Artru F, Bouthors A, Rolland B, Saffers P, Lollivier J, Lemaître E, Dharancy S, Lassailly G, Canva-Delcambre V, Duhamel A, Mathurin P. Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study. Hepatology 2017;66:1464-73. [PMID: 28459138 DOI: 10.1002/hep.29240] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 16.8] [Reference Citation Analysis]
268 Gustot T, Fernandez J, Szabo G, Albillos A, Louvet A, Jalan R, Moreau R, Moreno C. Sepsis in alcohol-related liver disease. J Hepatol 2017;67:1031-50. [PMID: 28647569 DOI: 10.1016/j.jhep.2017.06.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
269 Shen CJ, Kao CH, Hsu TY, Chen CY, Lin CL, Shih HM. Effect of alcohol intoxication on the risk of venous thromboembolism: A nationwide retrospective cohort study. Medicine (Baltimore) 2017;96:e8041. [PMID: 29049192 DOI: 10.1097/MD.0000000000008041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
270 Miyashima Y, Shibata M, Honma Y, Matsuoka H, Hiura M, Abe S, Harada M. Severe Alcoholic Hepatitis Effectively Treated with Vitamin E as an Add-on to Corticosteroids. Intern Med 2017;56:3293-7. [PMID: 29021453 DOI: 10.2169/internalmedicine.8767-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
271 Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol 2017; 23(36): 6549-6570 [PMID: 29085205 DOI: 10.3748/wjg.v23.i36.6549] [Cited by in CrossRef: 123] [Cited by in F6Publishing: 132] [Article Influence: 20.5] [Reference Citation Analysis]
272 Khoury T, Rotnemer-Golinkin D, Shabat Y, Zolotarovya L, Ilan Y. Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective Effects. J Clin Transl Hepatol 2017;5:208-15. [PMID: 28936402 DOI: 10.14218/JCTH.2017.00019] [Reference Citation Analysis]
273 Wang M, Shen G, Xu L, Liu X, Brown JM, Feng D, Ross RA, Gao B, Liangpunsakul S, Ju C. IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-κB activation in hepatic macrophages. J Hepatol 2017:S0168-8278(17)32263-8. [PMID: 28870670 DOI: 10.1016/j.jhep.2017.08.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
274 Yin S, Feng D. Interleukin-22 in the pathogenesis and potential treatment of liver diseases. Liver Research 2017;1:181-185. [DOI: 10.1016/j.livres.2017.09.003] [Reference Citation Analysis]
275 Dunne PDJ, Forrest EH. Review article: recent insights into clinical decision-making in severe alcoholic hepatitis. Aliment Pharmacol Ther 2017;46:274-81. [PMID: 28543549 DOI: 10.1111/apt.14144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
276 Su CW, Yang YY, Lin HC. Impact of etiological treatment on prognosis. Hepatol Int 2018;12:56-67. [PMID: 28702738 DOI: 10.1007/s12072-017-9807-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
277 Louvet A, Peck-Radosavljevic M. Evidence for a role of genetics in alcoholic hepatitis: Data from the STOPAH randomized controlled trial. J Hepatol 2017;67:12-4. [PMID: 28412295 DOI: 10.1016/j.jhep.2017.04.001] [Reference Citation Analysis]
278 Aday AW, Mitchell MC, Casey LC. Alcoholic hepatitis: current trends in management. Curr Opin Gastroenterol 2017;33:142-8. [PMID: 28282320 DOI: 10.1097/MOG.0000000000000359] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
279 Wieser V, Adolph TE, Enrich B, Kuliopulos A, Kaser A, Tilg H, Kaneider NC. Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors. Gut 2017;66:930-8. [PMID: 26858343 DOI: 10.1136/gutjnl-2015-310344] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
280 Mou HY, Nie HM, Hu XY. Gutuo Jiejiu decoction improves survival of patients with severe alcoholic hepatitis: A retrospective cohort study. World J Gastroenterol 2017; 23(16): 2957-2963 [PMID: 28522913 DOI: 10.3748/wjg.v23.i16.2957] [Reference Citation Analysis]
281 Lourens S, Sunjaya DB, Singal A, Liangpunsakul S, Puri P, Sanyal A, Ren X, Gores GJ, Radaeva S, Chalasani N, Crabb DW, Katz B, Kamath PS, Shah VH; TREAT Consortium. Acute Alcoholic Hepatitis: Natural History and Predictors of Mortality Using a Multicenter Prospective Study. Mayo Clin Proc Innov Qual Outcomes 2017;1:37-48. [PMID: 30225400 DOI: 10.1016/j.mayocpiqo.2017.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
282 Fung P, Pyrsopoulos N. Emerging concepts in alcoholic hepatitis. World J Hepatol 2017; 9(12): 567-585 [PMID: 28515843 DOI: 10.4254/wjh.v9.i12.567] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
283 Parker R, Im G, Jones F, Hernández OP, Nahas J, Kumar A, Wheatley D, Sinha A, Gonzalez-Reimers E, Sanchez-Pérez M, Ghezzi A, David MD, Corbett C, McCune A, Aithal GP, Holt A, Stewart S. Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study. J Gastroenterol 2017;52:1192-200. [PMID: 28389732 DOI: 10.1007/s00535-017-1336-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
284 Vergis N, Atkinson SR, Knapp S, Maurice J, Allison M, Austin A, Forrest EH, Masson S, McCune A, Patch D, Richardson P, Gleeson D, Ryder SD, Wright M, Thursz MR. In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA. Gastroenterology 2017;152:1068-1077.e4. [PMID: 28043903 DOI: 10.1053/j.gastro.2016.12.019] [Cited by in Crossref: 99] [Cited by in F6Publishing: 104] [Article Influence: 16.5] [Reference Citation Analysis]
285 Lee YS, Kim HJ, Kim JH, Yoo YJ, Kim TS, Kang SH, Suh SJ, Joo MK, Jung YK, Lee BJ, Seo YS, Yim HJ, Yeon JE, Kim JS, Park JJ, Um SH, Bak YT, Byun KS. Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2017;51:364-77. [PMID: 27636406 DOI: 10.1097/MCG.0000000000000674] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
286 Buzzetti E, Kalafateli M, Thorburn D, Davidson BR, Thiele M, Gluud LL, Del Giovane C, Askgaard G, Krag A, Tsochatzis E, Gurusamy KS. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. Cochrane Database Syst Rev 2017;3:CD011646. [PMID: 28368093 DOI: 10.1002/14651858.CD011646.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
287 Dhanda AD, Sinha A, Hunt V, Saleem S, Cramp ME, Collins PL. Infection does not increase long-term mortality in patients with acute severe alcoholic hepatitis treated with corticosteroids. World J Gastroenterol 2017; 23(11): 2052-2059 [PMID: 28373772 DOI: 10.3748/wjg.v23.i11.2052] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
288 Wruck W, Adjaye J. Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease. World J Hepatol 2017; 9(8): 443-454 [PMID: 28357032 DOI: 10.4254/wjh.v9.i8.443] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
289 Bjørkhaug ST, Skar V, Medhus AW, Tollisen A, Bramness JG, Valeur J. Chronic alcohol overconsumption may alter gut microbial metabolism: a retrospective study of 719 13C-D-xylose breath test results. Microb Ecol Health Dis 2017;28:1301725. [PMID: 28572752 DOI: 10.1080/16512235.2017.1301725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
290 Huang A, Chang B, Sun Y, Lin H, Li B, Teng G, Zou ZS. Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013: A large tertiary referral hospital experience from 7422 patients. Medicine (Baltimore) 2017;96:e6163. [PMID: 28207552 DOI: 10.1097/MD.0000000000006163] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
291 Sidhu SS, Goyal O, Kishore H, Sidhu S. New paradigms in management of alcoholic hepatitis: a review. Hepatol Int 2017;11:255-67. [PMID: 28247264 DOI: 10.1007/s12072-017-9790-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
292 Cramer P, Bresalier RS. Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors. Curr Gastroenterol Rep 2017;19:3. [PMID: 28124291 DOI: 10.1007/s11894-017-0540-6] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 18.8] [Reference Citation Analysis]
293 Breguet R, Ronot M, Goossens N, Hansen C, Giostra E, Majno P, Becker CD, Spahr L, Terraz S. Liver volume is a prognostic indicator for clinical outcome of patients with alcoholic hepatitis. Abdom Radiol (NY) 2017;42:460-7. [PMID: 27604894 DOI: 10.1007/s00261-016-0892-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
294 Shetty S, Venkatakrishnan L, Krishanveni J, Kumari S. Transjugular liver biopsy in severe alcoholic hepatitis. Indian J Gastroenterol 2017;36:23-6. [PMID: 28050823 DOI: 10.1007/s12664-016-0720-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
295 Gohar F, Richardson P. Alcoholic Hepatitis. In Clinical Practice 2017. [DOI: 10.1007/978-3-319-43126-0_6] [Reference Citation Analysis]
296 Mellinger JL, Fontana RJ. ICU Management of the Patient with Alcoholic Liver Disease. Evidence-Based Critical Care 2017. [DOI: 10.1007/978-3-319-43341-7_69] [Reference Citation Analysis]
297 O’gurek DT. Diseases of the Liver. Family Medicine 2017. [DOI: 10.1007/978-3-319-04414-9_97] [Reference Citation Analysis]
298 Kojima-Yuasa A, Goto M, Yoshikawa E, Morita Y, Sekiguchi H, Sutoh K, Usumi K, Matsui-Yuasa I. Protective Effects of Hydrolyzed Nucleoproteins from Salmon Milt against Ethanol-Induced Liver Injury in Rats. Mar Drugs 2016;14:E232. [PMID: 27999369 DOI: 10.3390/md14120232] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
299 Zeng T, Zhang CL, Xiao M, Yang R, Xie KQ. Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical Trials. Front Immunol 2016;7:538. [PMID: 27965666 DOI: 10.3389/fimmu.2016.00538] [Cited by in Crossref: 62] [Cited by in F6Publishing: 72] [Article Influence: 8.9] [Reference Citation Analysis]
300 Watanabe Y, Kamimura K, Iwasaki T, Abe H, Takahashi S, Mizuno KI, Takeuchi M, Eino A, Narita I, Terai S. Case of severe alcoholic hepatitis treated with granulocytapheresis. World J Clin Cases 2016; 4(11): 369-374 [PMID: 27900326 DOI: 10.12998/wjcc.v4.i11.369] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
301 Fuster D, Sanvisens A, Bolao F, Rivas I, Tor J, Muga R. Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol 2016; 8(31): 1295-1308 [PMID: 27872681 DOI: 10.4254/wjh.v8.i31.1295] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
302 Kim HY, Kim CW, Kim TY, Song DS, Sinn DH, Yoon EL, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Kim JH, Yim HJ, Kim SE, Baik SK, Lee BS, Jang JY, Kim YS, Kim SG, Yang JM, Sohn JH, Lee HJ, Park SH, Choi EH, Kim DJ, Korean Acute-on-Chronic Liver Failure Study Group. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis. World J Gastroenterol 2016; 22(41): 9205-9213 [PMID: 27895407 DOI: 10.3748/wjg.v22.i41.9205] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
303 Cabezas J, Bataller R. Alcoholic hepatitis: should we combine old drugs for better results? Hepatol Int 2016;10:851-3. [PMID: 27638331 DOI: 10.1007/s12072-016-9768-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
304 Karakike E, Moreno C, Gustot T. Infections in severe alcoholic hepatitis. Ann Gastroenterol 2017;30:152-60. [PMID: 28243035 DOI: 10.20524/aog.2016.0101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
305 Odena G, Chen J, Lozano JJ, Altamirano J, Rodrigo-Torres D, Affo S, Morales-Ibanez O, Matsushita H, Zou J, Dumitru R, Caballeria J, Gines P, Arroyo V, You M, Rautou PE, Valla D, Crews F, Seki E, Sancho-Bru P, Bataller R. LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis. Sci Rep 2016;6:35610. [PMID: 27752144 DOI: 10.1038/srep35610] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
306 Mandrekar P, Bataller R, Tsukamoto H, Gao B. Alcoholic hepatitis: Translational approaches to develop targeted therapies. Hepatology 2016;64:1343-55. [PMID: 26940353 DOI: 10.1002/hep.28530] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 11.1] [Reference Citation Analysis]
307 Caballeria J. Is there a role for pentoxifylline in the treatment of alcoholic hepatitis? Gastroenterología y Hepatología (English Edition) 2016;39:560-565. [DOI: 10.1016/j.gastre.2016.07.004] [Reference Citation Analysis]
308 Bukong TN, Iracheta-Vellve A, Saha B, Ambade A, Satishchandran A, Gyongyosi B, Lowe P, Catalano D, Kodys K, Szabo G. Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease. Hepatology 2016;64:1057-71. [PMID: 27302565 DOI: 10.1002/hep.28680] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
309 Li Z, Bridges B, Olson J, Weinman SA. The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3. Oncogene 2017;36:1887-98. [PMID: 27669435 DOI: 10.1038/onc.2016.359] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
310 Tilg H, Moschen AR, Szabo G. Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology 2016;64:955-65. [PMID: 26773297 DOI: 10.1002/hep.28456] [Cited by in Crossref: 182] [Cited by in F6Publishing: 187] [Article Influence: 26.0] [Reference Citation Analysis]
311 Gallegos-Orozco JF, Charlton MR. Alcoholic Liver Disease and Liver Transplantation. Clin Liver Dis 2016;20:521-34. [PMID: 27373614 DOI: 10.1016/j.cld.2016.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
312 Phillips PK, Lucey MR. Acute Alcoholic Hepatitis: Therapy. Clin Liver Dis 2016;20:509-19. [PMID: 27373613 DOI: 10.1016/j.cld.2016.02.015] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
313 Dugum MF, McCullough AJ. Acute Alcoholic Hepatitis, the Clinical Aspects. Clin Liver Dis 2016;20:499-508. [PMID: 27373612 DOI: 10.1016/j.cld.2016.02.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
314 Glavind E, Aagaard NK, Grønbæk H, Møller HJ, Orntoft NW, Vilstrup H, Thomsen KL. Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis. PLoS One 2016;11:e0158388. [PMID: 27379798 DOI: 10.1371/journal.pone.0158388] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
315 Beisel C, Blessin U, Schulze Zur Wiesch J, Wehmeyer MH, Lohse AW, Benten D, Kluwe J. Infections complicating severe alcoholic hepatitis: Enterococcus species represent the most frequently identified pathogen. Scand J Gastroenterol 2016;51:807-13. [PMID: 27000534 DOI: 10.3109/00365521.2016.1157887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
316 Qu BG, Bi W, Jia YG, Liu YX, Wang H, Su JL, Liu LL, Wang ZD, Wang YF, Han XH, Pan JD, Ren GY, Hu WJ. Association between circulating inflammatory molecules and alcoholic liver disease in men. Cell Stress Chaperones 2016;21:865-72. [PMID: 27329162 DOI: 10.1007/s12192-016-0711-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
317 Saberi B, Dadabhai AS, Jang YY, Gurakar A, Mezey E. Current Management of Alcoholic Hepatitis and Future Therapies. J Clin Transl Hepatol 2016;4:113-22. [PMID: 27350941 DOI: 10.14218/JCTH.2016.00006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
318 Hashimoto JG, Wiren KM, Wilhelm CJ. A neurotoxic alcohol exposure paradigm does not induce hepatic encephalopathy. Neurotoxicol Teratol 2016;56:35-40. [PMID: 27268733 DOI: 10.1016/j.ntt.2016.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
319 Singal AK, Kodali S, Vucovich LA, Darley-Usmar V, Schiano TD. Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. Alcohol Clin Exp Res. 2016;40:1390-1402. [PMID: 27254289 DOI: 10.1111/acer.13108] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
320 Thursz M, Morgan TR. Treatment of Severe Alcoholic Hepatitis. Gastroenterology 2016;150:1823-34. [PMID: 26948886 DOI: 10.1053/j.gastro.2016.02.074] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
321 Andrade P, Silva M, Rodrigues S, Lopes J, Lopes S, Macedo G. Alcoholic hepatitis histological score has high accuracy to predict 90-day mortality and response to steroids. Dig Liver Dis 2016;48:656-60. [PMID: 27026082 DOI: 10.1016/j.dld.2016.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
322 Farooq MO, Bataller R. Pathogenesis and Management of Alcoholic Liver Disease. Dig Dis 2016;34:347-55. [PMID: 27170388 DOI: 10.1159/000444545] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
323 Louvet A. Restoration of bactericidal activity of neutrophils by myeloperoxidase release: A new perspective for preventing infection in alcoholic cirrhosis. J Hepatol 2016;64:1006-7. [PMID: 26883848 DOI: 10.1016/j.jhep.2016.02.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
324 Ravi S, Bade KS, Hasanin M, Singal AK. Ammonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis. Gastroenterol Rep (Oxf) 2017;5:232-6. [PMID: 27132633 DOI: 10.1093/gastro/gow010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
325 Bastarrica MI, Urbistondo DM. Protocolo diagnóstico de la elevación de las transaminasas en el paciente alcohólico. Medicine - Programa de Formación Médica Continuada Acreditado 2016;12:591-595. [DOI: 10.1016/j.med.2016.05.008] [Reference Citation Analysis]
326 Boussif A, Rolas L, Weiss E, Bouriche H, Moreau R, Périanin A. Impaired intracellular signaling, myeloperoxidase release and bactericidal activity of neutrophils from patients with alcoholic cirrhosis. J Hepatol 2016;64:1041-8. [PMID: 26719020 DOI: 10.1016/j.jhep.2015.12.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
327 Hmoud BS, Patel K, Bataller R, Singal AK. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver Int 2016;36:721-8. [PMID: 26279269 DOI: 10.1111/liv.12939] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
328 Shasthry SM, Sarin SK. New treatment options for alcoholic hepatitis. World J Gastroenterol 2016; 22(15): 3892-3906 [PMID: 27099434 DOI: 10.3748/wjg.v22.i15.3892] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
329 Kim SH, Kim BG, Kim W, Oh S, Kim HY, Jung YJ, Jeong JB, Kim JW, Lee KL. Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis. J Gastroenterol Hepatol 2016;31:814-21. [PMID: 26513408 DOI: 10.1111/jgh.13220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
330 Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G; NIAAA Alcoholic Hepatitis Consortia. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology 2016;150:785-90. [PMID: 26921783 DOI: 10.1053/j.gastro.2016.02.042] [Cited by in Crossref: 263] [Cited by in F6Publishing: 263] [Article Influence: 37.6] [Reference Citation Analysis]
331 Dubuquoy L. Lipocalin 2 highlights the complex role of neutrophils in alcoholic liver disease. J Hepatol 2016;64:770-2. [PMID: 26812070 DOI: 10.1016/j.jhep.2016.01.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
332 Akriviadis E, Sinakos E. Treatment of alcoholic hepatitis: is this a "dead-end"? Ann Gastroenterol 2016;29:236-7. [PMID: 27065743 DOI: 10.20524/aog.2016.0023] [Reference Citation Analysis]
333 Moreno C, Deltenre P, Senterre C, Louvet A, Gustot T, Bastens B, Hittelet A, Piquet MA, Laleman W, Orlent H, Lasser L, Sersté T, Starkel P, De Koninck X, Negrin Dastis S, Delwaide J, Colle I, de Galocsy C, Francque S, Langlet P, Putzeys V, Reynaert H, Degré D, Trépo E. Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids. Gastroenterology 2016;150:903-10.e8. [PMID: 26764182 DOI: 10.1053/j.gastro.2015.12.038] [Cited by in Crossref: 91] [Cited by in F6Publishing: 95] [Article Influence: 13.0] [Reference Citation Analysis]
334 Moreau R. Acute-on-chronic liver failure: a new syndrome in cirrhosis. Clin Mol Hepatol 2016;22:1-6. [PMID: 27044760 DOI: 10.3350/cmh.2016.22.1.1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
335 Davies O, Dezfulian C. Alcoholic hepatitis: Yes to prednisolone and no to pentoxifylline. F1000Res 2016;5:395. [DOI: 10.12688/f1000research.8336.1] [Reference Citation Analysis]
336 Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol. 2016;51:511-519. [PMID: 26939970 DOI: 10.1007/s00535-016-1190-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 12.3] [Reference Citation Analysis]
337 Choudhary NS, Kumar N, Saigal S, Rai R, Saraf N, Soin AS. Liver Transplantation for Alcohol-Related Liver Disease. J Clin Exp Hepatol 2016;6:47-53. [PMID: 27194896 DOI: 10.1016/j.jceh.2016.02.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
338 Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol 2016;13:131-49. [PMID: 26837712 DOI: 10.1038/nrgastro.2015.219] [Cited by in Crossref: 194] [Cited by in F6Publishing: 173] [Article Influence: 27.7] [Reference Citation Analysis]
339 Maiwall R, Chandel SS, Wani Z, Kumar S, Sarin SK. SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis. Dig Dis Sci 2016;61:920-9. [PMID: 26470868 DOI: 10.1007/s10620-015-3921-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
340 Kim HY, Chang Y, Park JY, Ahn H, Cho H, Han SJ, Oh S, Kim D, Jung YJ, Kim BG, Lee KL, Kim W. Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism. J Gastroenterol Hepatol 2016;31:427-33. [PMID: 26260091 DOI: 10.1111/jgh.13084] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
341 Roth N, Kanel G, Kaplowitz N. Alcoholic foamy degeneration and alcoholic fatty liver with jaundice: Often overlooked causes of jaundice and hepatic decompensation that can mimic alcoholic hepatitis. Clin Liver Dis (Hoboken) 2015;6:145-8. [PMID: 31041013 DOI: 10.1002/cld.520] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
342 Kim MS, Ong M, Qu X. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination? World J Gastroenterol 2016; 22(1): 8-23 [PMID: 26755857 DOI: 10.3748/wjg.v22.i1.8] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
343 Cheong J, Stein E, Bataller R. Diagnostic Approaches and Clinical End Points of Treatment in Alcoholic Liver Disease. Alcoholic and Non-Alcoholic Fatty Liver Disease 2016. [DOI: 10.1007/978-3-319-20538-0_10] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
344 Kasten P. Alkoholinduzierte Leberschäden. Praxis der Hepatologie 2016. [DOI: 10.1007/978-3-642-41620-0_17] [Reference Citation Analysis]
345 Petrasek J, Szabo G. Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets, and Liver Transplantation. Alcoholic and Non-Alcoholic Fatty Liver Disease 2016. [DOI: 10.1007/978-3-319-20538-0_15] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
346 Kasten P. Alkoholinduzierte Leberschäden. Praxis der Hepatologie 2016. [DOI: 10.1007/978-3-642-41620-0_150] [Reference Citation Analysis]
347 Lefkowitch JH. Steatosis, Steatohepatitis and Related Conditions. Scheuer's Liver Biopsy Interpretation 2016. [DOI: 10.1016/b978-0-7020-5548-5.00007-4] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
348 Honigbaum S, Lucas J, Schwarz K. Cirrhosis. Encyclopedia of Food and Health 2016. [DOI: 10.1016/b978-0-12-384947-2.00164-1] [Reference Citation Analysis]
349 Bath RK, Wu GY. Hepatitis. Clinical Gastroenterology 2016. [DOI: 10.1007/978-3-319-33317-5_8] [Reference Citation Analysis]
350 Latchoumycandane C, Hanouneh M, Nagy LE, McIntyre TM. Inflammatory PAF Receptor Signaling Initiates Hedgehog Signaling and Kidney Fibrogenesis During Ethanol Consumption. PLoS One 2015;10:e0145691. [PMID: 26720402 DOI: 10.1371/journal.pone.0145691] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
351 Rudler M, Thibault V, Mouri S, Akhavan S, Mallet M, Charlotte F, Poynard T, Thabut D. Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening? Eur J Gastroenterol Hepatol 2015;27:1367-71. [PMID: 26308710 DOI: 10.1097/MEG.0000000000000459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
352 Dubuquoy L, Louvet A, Lassailly G, Truant S, Boleslawski E, Artru F, Maggiotto F, Gantier E, Buob D, Leteurtre E, Cannesson A, Dharancy S, Moreno C, Pruvot FR, Bataller R, Mathurin P. Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut 2015;64:1949-60. [PMID: 25731872 DOI: 10.1136/gutjnl-2014-308410] [Cited by in Crossref: 103] [Cited by in F6Publishing: 98] [Article Influence: 12.9] [Reference Citation Analysis]
353 Altamirano J, Orman ES, Bataller R. Alcoholic Liver Disease. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch103] [Reference Citation Analysis]
354 Caballeria J. [Is there a role for pentoxifylline in the treatment of alcoholic hepatitis?]. Gastroenterol Hepatol 2016;39:560-5. [PMID: 26589540 DOI: 10.1016/j.gastrohep.2015.10.004] [Reference Citation Analysis]
355 Dhanda AD, Collins PL. Immune dysfunction in acute alcoholic hepatitis. World J Gastroenterol 2015; 21(42): 11904-11913 [PMID: 26576079 DOI: 10.3748/wjg.v21.i42.11904] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
356 Torok NJ. Update on Alcoholic Hepatitis. Biomolecules. 2015;5:2978-2986. [PMID: 26540078 DOI: 10.3390/biom5042978] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
357 Rosa-Toledo O, Almeida-Chuffa LG, Martinez M, Felipe-Pinheiro PF, Padovani CR, Martinez FE. Maternal separation on the ethanol-preferring adult rat liver structure. Ann Hepatol 2015;14:910-8. [PMID: 26436364 DOI: 10.5604/16652681.1171783] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
358 Han SH, Suk KT, Kim DJ, Kim MY, Baik SK, Kim YD, Cheon GJ, Choi DH, Ham YL, Shin DH, Kim EJ. Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol 2015;27:1300-6. [PMID: 26302024 DOI: 10.1097/MEG.0000000000000458] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 9.5] [Reference Citation Analysis]
359 Banerjee A, Abdelmegeed MA, Jang S, Song BJ. Increased Sensitivity to Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats. PLoS One 2015;10:e0140498. [PMID: 26484872 DOI: 10.1371/journal.pone.0140498] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
360 Parikh ND, Schlansky B. Comparative Effectiveness of Medical Therapies for Severe Alcoholic Hepatitis: Guidance at Last? Gastroenterology 2015;149:857-9. [PMID: 26302486 DOI: 10.1053/j.gastro.2015.08.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
361 Punzalan CS, Bukong TN, Szabo G. Alcoholic hepatitis and HCV interactions in the modulation of liver disease. J Viral Hepat 2015;22:769-76. [PMID: 25754333 DOI: 10.1111/jvh.12399] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
362 Xu MJ, Cai Y, Wang H, Altamirano J, Chang B, Bertola A, Odena G, Lu J, Tanaka N, Matsusue K, Matsubara T, Mukhopadhyay P, Kimura S, Pacher P, Gonzalez FJ, Bataller R, Gao B. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology 2015;149:1030-41.e6. [PMID: 26099526 DOI: 10.1053/j.gastro.2015.06.009] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 11.8] [Reference Citation Analysis]
363 Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology 2015;149:958-70.e12. [PMID: 26091937 DOI: 10.1053/j.gastro.2015.06.006] [Cited by in Crossref: 104] [Cited by in F6Publishing: 112] [Article Influence: 13.0] [Reference Citation Analysis]
364 Yepes JF. Hepatic Disease. The ADA Practical Guide to Patients with Medical Conditions 2015. [DOI: 10.1002/9781119121039.ch6] [Reference Citation Analysis]
365 Pang JX, Ross E, Borman MA, Zimmer S, Kaplan GG, Heitman SJ, Swain MG, Burak KW, Quan H, Myers RP. Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data. BMC Gastroenterol 2015;15:116. [PMID: 26362871 DOI: 10.1186/s12876-015-0348-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
366 Wang HJ, Murray GJ, Jung MK. Host homeostatic responses to alcohol-induced cellular stress in animal models of alcoholic liver disease. Expert Review of Gastroenterology & Hepatology 2015;9:1193-1205. [DOI: 10.1586/17474124.2015.1069705] [Reference Citation Analysis]
367 Venetz D. Medikamentöse Therapie schwerer alkoholischer Steatohepatitis. Gastroenterologe 2015;10:437-437. [DOI: 10.1007/s11377-015-0006-z] [Reference Citation Analysis]
368 Lanthier N, Rubbia-Brandt L, Lin-Marq N, Clément S, Frossard JL, Goossens N, Hadengue A, Spahr L. Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis. J Hepatol 2015;63:609-21. [PMID: 25872168 DOI: 10.1016/j.jhep.2015.04.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
369 Michelena J, Altamirano J, Abraldes JG, Affò S, Morales-Ibanez O, Sancho-Bru P, Dominguez M, García-Pagán JC, Fernández J, Arroyo V, Ginès P, Louvet A, Mathurin P, Mehal WZ, Caballería J, Bataller R. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology 2015;62:762-72. [PMID: 25761863 DOI: 10.1002/hep.27779] [Cited by in Crossref: 182] [Cited by in F6Publishing: 156] [Article Influence: 22.8] [Reference Citation Analysis]
370 Amieva-Balmori M, Mejia-Loza SMI, Ramos-González R, Zamarripa-Dorsey F, García-Ruiz E, Pérez y López N, Juárez-Valdés EI, López-Luria A, Remes-Troche JM. Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best? World J Hepatol 2015; 7(17): 2119-2126 [PMID: 26301054 DOI: 10.4254/wjh.v7.i17.2119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
371 Louvet A, Labreuche J, Artru F, Boursier J, Kim DJ, O'Grady J, Trépo E, Nahon P, Ganne-Carrié N, Naveau S, Diaz E, Gustot T, Lassailly G, Cannesson-Leroy A, Canva-Delcambre V, Dharancy S, Park SH, Moreno C, Morgan TR, Duhamel A, Mathurin P. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis. Gastroenterology 2015;149:398-406.e8; quiz e16-7. [PMID: 25935634 DOI: 10.1053/j.gastro.2015.04.044] [Cited by in Crossref: 110] [Cited by in F6Publishing: 112] [Article Influence: 13.8] [Reference Citation Analysis]
372 Hayes P, Williams M. Patterns of alcohol-associated liver damage. Alcohol abuse and liver disease 2015. [DOI: 10.1002/9781118887318.ch8] [Reference Citation Analysis]
373 Ferguson J. Abnormal liver tests in the context of alcohol excess. Alcohol abuse and liver disease 2015. [DOI: 10.1002/9781118887318.ch12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
374 Rahimi E, Pan JJ. Prognostic models for alcoholic hepatitis. Biomark Res 2015;3:20. [PMID: 26203357 DOI: 10.1186/s40364-015-0046-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
375 Rachakonda V, Gabbert C, Raina A, Li H, Malik S, DeLany JP, Behari J. Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines. Alcohol Clin Exp Res. 2014;38:2712-2721. [PMID: 25421508 DOI: 10.1111/acer.12558] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
376 Gao B, Shah VH. Combination therapy: New hope for alcoholic hepatitis? Clin Res Hepatol Gastroenterol. 2015;39 Suppl 1:S7-S11. [PMID: 26193867 DOI: 10.1016/j.clinre.2015.05.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
377 Roh YS, Zhang B, Loomba R, Seki E. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am J Physiol Gastrointest Liver Physiol 2015;309:G30-41. [PMID: 25930080 DOI: 10.1152/ajpgi.00031.2015] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 11.8] [Reference Citation Analysis]
378 Guerra MT, Nathanson MH. Calcium signaling and secretion in cholangiocytes. Pancreatology 2015;15:S44-8. [PMID: 26100660 DOI: 10.1016/j.pan.2015.05.477] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
379 Jinjuvadia R, Liangpunsakul S; Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium. Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States. J Clin Gastroenterol 2015;49:506-11. [PMID: 25198164 DOI: 10.1097/MCG.0000000000000161] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
380 Sanyal AJ, Gao B, Szabo G. Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis. Gastroenterology 2015;149:4-9. [PMID: 26008859 DOI: 10.1053/j.gastro.2015.05.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
381 Yamashita H, Goto M, Matsui-Yuasa I, Kojima-Yuasa A. Ecklonia cava Polyphenol Has a Protective Effect against Ethanol-Induced Liver Injury in a Cyclic AMP-Dependent Manner. Mar Drugs 2015;13:3877-91. [PMID: 26096275 DOI: 10.3390/md13063877] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
382 Osaki K, Shimizu Y, Yamamoto T, Miyake F, Kondo S, Yamaguchi H. Improvement of liver function by the administration of oyster extract as a dietary supplement to habitual alcohol drinkers: A pilot study. Exp Ther Med 2015;10:705-10. [PMID: 26622379 DOI: 10.3892/etm.2015.2563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
383 Liu M, Dou Y, Sun R, Zhang Y, Liu Y. Molecular mechanisms for alcoholic hepatitis based on analysis of gene expression profile. Hepat Mon 2015;15:e27336. [PMID: 26045708 DOI: 10.5812/hepatmon.15(5)2015.27336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
384 Latchoumycandane C, Nagy LE, McIntyre TM. Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumption. Free Radic Biol Med 2015;86:179-90. [PMID: 26003521 DOI: 10.1016/j.freeradbiomed.2015.05.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
385 Wang MT, Lee WJ, Huang TY, Chu CL, Hsieh CH. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. Br J Clin Pharmacol 2014;78:619-29. [PMID: 25279406 DOI: 10.1111/bcp.12336] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 8.1] [Reference Citation Analysis]
386 Fuster D, Sanvisens A, Bolao F, Zuluaga P, Rivas I, Tor J, Muga R. Markers of inflammation and mortality in a cohort of patients with alcohol dependence. Medicine (Baltimore). 2015;94:e607. [PMID: 25761182 DOI: 10.1097/md.0000000000000607] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
387 Evren E, Yurtcu E. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiol (Praha) 2015;60:351-6. [PMID: 25937395 DOI: 10.1007/s12223-015-0399-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
388 Vassallo G, Mirijello A, Ferrulli A, Antonelli M, Landolfi R, Gasbarrini A, Addolorato G. Review article: Alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease. Aliment Pharmacol Ther 2015;41:917-27. [PMID: 25809237 DOI: 10.1111/apt.13164] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 9.5] [Reference Citation Analysis]
389 Tijera FHDL, Servín-Caamaño AI, Serralde-Zúñiga AE, Cruz-Herrera J, Pérez-Torres E, Abdo-Francis JM, Salas-Gordillo F, Pérez-Hernández JL. Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis. World J Gastroenterol 2015; 21(16): 4975-4985 [PMID: 25945012 DOI: 10.3748/wjg.v21.i16.4975] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
390 Gurusamy KS, Tsochatzis E, Thorburn D, Davidson BR. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): a network meta-analysis. Cochrane Database of Systematic Reviews 2015. [DOI: 10.1002/14651858.cd011646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
391 Pang JX, Ross E, Borman MA, Zimmer S, Kaplan GG, Heitman SJ, Swain MG, Burak K, Quan H, Myers RP. Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study. Can J Gastroenterol Hepatol 2015;29:131-8. [PMID: 25855876 DOI: 10.1155/2015/814827] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
392 Mathurin P, Bataller R. Trends in the management and burden of alcoholic liver disease. J Hepatol 2015;62:S38-46. [PMID: 25920088 DOI: 10.1016/j.jhep.2015.03.006] [Cited by in Crossref: 187] [Cited by in F6Publishing: 193] [Article Influence: 23.4] [Reference Citation Analysis]
393 Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol 2015;12:231-42. [PMID: 25782093 DOI: 10.1038/nrgastro.2015.35] [Cited by in Crossref: 476] [Cited by in F6Publishing: 473] [Article Influence: 59.5] [Reference Citation Analysis]
394 Arroyo V, Moreau R, Jalan R, Ginès P; EASL-CLIF Consortium CANONIC Study. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. J Hepatol 2015;62:S131-43. [PMID: 25920082 DOI: 10.1016/j.jhep.2014.11.045] [Cited by in Crossref: 291] [Cited by in F6Publishing: 281] [Article Influence: 36.4] [Reference Citation Analysis]
395 Khirfan K, Hanson J, Alcorn J. Portal hypertension in alcoholic liver disease: can it be fixed? Dig Dis Sci 2015;60:838-40. [PMID: 25647760 DOI: 10.1007/s10620-015-3562-7] [Reference Citation Analysis]
396 Almeida JRDS, Araújo RC, Castilho GVD, Stahelin L, Pandolfi LDR, Silva CQ. USEFULNESS OF A NEW PROGNOSTIC INDEX FOR ALCOHOLIC HEPATITIS. Arq Gastroenterol 2015;52:22-26. [DOI: 10.1590/s0004-28032015000100006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
397 Bataller R, Mandrekar P. Identifying molecular targets to improve immune function in alcoholic hepatitis. Gastroenterology 2015;148:498-501. [PMID: 25613314 DOI: 10.1053/j.gastro.2015.01.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
398 Okushin K, Takahashi Y, Yamamichi N, Shimamoto T, Enooku K, Fujinaga H, Tsutsumi T, Shintani Y, Sakaguchi Y, Ono S, Kodashima S, Fujishiro M, Moriya K, Yotsuyanagi H, Mitsushima T, Koike K. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. BMC Gastroenterol 2015;15:25. [PMID: 25880912 DOI: 10.1186/s12876-015-0247-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
399 Karaca G, Xie G, Moylan C, Swiderska-Syn M, Guy CD, Krüger L, Machado MV, Choi SS, Michelotti GA, Burkly LC, Diehl AM. Role of Fn14 in acute alcoholic steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol 2015;308:G325-34. [PMID: 25524063 DOI: 10.1152/ajpgi.00429.2013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
400 Mathews S, Feng D, Maricic I, Ju C, Kumar V, Gao B. Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. Cell Mol Immunol. 2016;13:206-216. [PMID: 25661730 DOI: 10.1038/cmi.2015.06] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
401 Pathil-warth A, Stremmel W, Berg T, Benckert J, Wiegand J, Pfersdorff M, Kraus M, Banasch M, Schmidt WE, Wasmuth H, Trautwein C. Entzündliche Lebererkrankungen. Viszeralmedizin 2015. [DOI: 10.1007/978-3-642-14301-4_23] [Reference Citation Analysis]
402 O’gurek DT. Diseases of the Liver. Family Medicine 2015. [DOI: 10.1007/978-1-4939-0779-3_97-1] [Reference Citation Analysis]
403 Fuster D, Sanvisens A, Bolao F, Serra I, Rivas I, Tor J, Muga R. Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients. J Viral Hepat 2015;22:18-24. [PMID: 25131721 DOI: 10.1111/jvh.12290] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
404 Marik PE. Acute and Chronic Liver Disease. Evidence-Based Critical Care 2015. [DOI: 10.1007/978-3-319-11020-2_34] [Reference Citation Analysis]
405 Garcia-Ruiz C, Mato JM, Vance D, Kaplowitz N, Fernández-Checa JC. Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways. J Hepatol 2015;62:219-33. [PMID: 25281863 DOI: 10.1016/j.jhep.2014.09.023] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
406 Shoeb M, Ansari NH, Srivastava SK, Ramana KV. 4-Hydroxynonenal in the pathogenesis and progression of human diseases. Curr Med Chem 2014;21:230-7. [PMID: 23848536 DOI: 10.2174/09298673113209990181] [Cited by in Crossref: 99] [Cited by in F6Publishing: 104] [Article Influence: 11.0] [Reference Citation Analysis]
407 Rachakonda V, Gabbert C, Raina A, Bell LN, Cooper S, Malik S, Behari J. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways. PLoS One 2014;9:e113860. [PMID: 25461442 DOI: 10.1371/journal.pone.0113860] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
408 Kawaguchi Y, Sugawara Y, Akamatsu N, Kaneko J, Tanaka T, Tamura S, Aoki T, Sakamoto Y, Hasegawa K, Kokudo N. Perceptions of post-transplant recidivism in liver transplantation for alcoholic liver disease. World J Hepatol 2014; 6(11): 812-817 [PMID: 25429319 DOI: 10.4254/wjh.v6.i11.812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
409 Bang HA, Kwon YH, Lee MJ, Lee WC. Trends in the epidemiological aspects and mortality of alcoholic liver disease in Korea in the decade between 2000 and 2009. J Clin Med Res 2015;7:91-6. [PMID: 25436025 DOI: 10.14740/jocmr1975e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
410 Affò S, Morales-Ibanez O, Rodrigo-Torres D, Altamirano J, Blaya D, Dapito DH, Millán C, Coll M, Caviglia JM, Arroyo V, Caballería J, Schwabe RF, Ginès P, Bataller R, Sancho-Bru P. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Gut 2014;63:1782-92. [PMID: 24415562 DOI: 10.1136/gutjnl-2013-306098] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 10.8] [Reference Citation Analysis]
411 Testino G, Burra P, Bonino F, Piani F, Sumberaz A, Peressutti R, Castiglione AG, Patussi V, Fanucchi T, Ancarani O, Cerce GD, Iannini AT, Greco G, Mosti A, Durante M, Babocci P, Quartini M, Mioni D, Aricò S, Baselice A, Leone S, Lozer F, Scafato E, Borro P. Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement. World J Gastroenterol 2014; 20(40): 14642-14651 [PMID: 25356027 DOI: 10.3748/wjg.v20.i40.14642] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
412 Kim W, Kim DJ. Severe alcoholic hepatitis-current concepts, diagnosis and treatment options. World J Hepatol 2014; 6(10): 688-695 [PMID: 25349640 DOI: 10.4254/wjh.v6.i10.688] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
413 Higuera-de la Tijera F, Servín-caamaño AI, Pérez-torres E, Salas-gordillo F, Abdo-francis JM, Pérez-hernández JL, Kershenobich D. Main clinical factors influencing early mortality in a cohort of patients with severe alcoholic hepatitis, and evaluation trough ROC curves of different prognostic scoring systems. Revista Médica Del Hospital General De México 2014;77:160-6. [DOI: 10.1016/j.hgmx.2014.10.003] [Reference Citation Analysis]
414 Ambade A, Catalano D, Lim A, Kopoyan A, Shaffer SA, Mandrekar P. Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury. J Hepatol 2014;61:903-11. [PMID: 24859453 DOI: 10.1016/j.jhep.2014.05.024] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
415 Spengler EK, Dunkelberg J, Schey R. Alcoholic hepatitis: current management. Dig Dis Sci 2014;59:2357-66. [PMID: 24798996 DOI: 10.1007/s10620-014-3173-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
416 Orntoft NW, Sandahl TD, Jepsen P, Vilstrup H. Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark. Clin Gastroenterol Hepatol 2014;12:1739-44.e1. [PMID: 24780287 DOI: 10.1016/j.cgh.2014.04.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
417 Suk KT, Kim MY, Baik SK. Alcoholic liver disease: Treatment. World J Gastroenterol 2014; 20(36): 12934-12944 [PMID: 25278689 DOI: 10.3748/wjg.v20.i36.12934] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
418 Shoreibah M, Anand BS, Singal AK. Alcoholic hepatitis and concomitant hepatitis C virus infection. World J Gastroenterol 2014; 20(34): 11929-11934 [PMID: 25232227 DOI: 10.3748/wjg.v20.i34.11929] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
419 Xu J, Liu X, Gao B, Karin M, Tsukamoto H, Brenner D, Kisseleva T. New Approaches for Studying Alcoholic Liver Disease. Curr Pathobiol Rep 2014;2:171-83. [PMID: 26594598 DOI: 10.1007/s40139-014-0053-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
420 Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, Osna NA, Kharbanda KK, Seth D, Bautista A. Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol. 2014;97:492-510. [PMID: 25217800 DOI: 10.1016/j.yexmp.2014.09.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
421 Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol 2014; 20(33): 11684-11699 [PMID: 25206273 DOI: 10.3748/wjg.v20.i33.11684] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 92] [Article Influence: 9.3] [Reference Citation Analysis]
422 Singh V, Sharma AK, Narasimhan RL, Bhalla A, Sharma N, Sharma R. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am J Gastroenterol 2014;109:1417-23. [PMID: 24935272 DOI: 10.1038/ajg.2014.154] [Cited by in Crossref: 148] [Cited by in F6Publishing: 142] [Article Influence: 16.4] [Reference Citation Analysis]
423 Moreau R, Rautou PE. G-CSF therapy for severe alcoholic hepatitis: targeting liver regeneration or neutrophil function? Am J Gastroenterol 2014;109:1424-6. [PMID: 25196873 DOI: 10.1038/ajg.2014.250] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
424 Toshikuni N, Tsutsumi M, Arisawa T. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8393-8406 [PMID: 25024597 DOI: 10.3748/wjg.v20.i26.8393] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 86] [Article Influence: 9.2] [Reference Citation Analysis]
425 Streba LA, Vere CC, Streba CT, Ciurea ME. Focus on alcoholic liver disease: from nosography to treatment. World J Gastroenterol 2014;20:8040-7. [PMID: 25009375 DOI: 10.3748/wjg.v20.i25.8040] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
426 Vonghia L, Michielsen P, Dom G, Francque S. Diagnostic challenges in alcohol use disorder and alcoholic liver disease. World J Gastroenterol 2014; 20(25): 8024-8032 [PMID: 25009373 DOI: 10.3748/wjg.v20.i25.8024] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
427 Parés A, Mas A. Extracorporeal liver support in severe alcoholic hepatitis. World J Gastroenterol 2014; 20(25): 8011-8017 [PMID: 25009371 DOI: 10.3748/wjg.v20.i25.8011] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
428 Keenan R, Davidson B. Alcohol-related liver disease and nutrition. Advanced Nutrition and Dietetics in Gastroenterology 2014. [DOI: 10.1002/9781118872796.ch4.3] [Reference Citation Analysis]
429 Celli R, Zhang X. Pathology of Alcoholic Liver Disease. J Clin Transl Hepatol 2014;2:103-9. [PMID: 26357621 DOI: 10.14218/JCTH.2014.00010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
430 Kumar K, Mohindra S, Raj M, Choudhuri G. Procalcitonin as a marker of sepsis in alcoholic hepatitis. Hepatol Int. 2014;8:436-442. [PMID: 26202645 DOI: 10.1007/s12072-014-9540-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
431 Chayanupatkul M, Liangpunsakul S. Alcoholic hepatitis: A comprehensive review of pathogenesis and treatment. World J Gastroenterol 2014; 20(20): 6279-6286 [PMID: 24876748 DOI: 10.3748/wjg.v20.i20.6279] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
432 Hazeldine S, Sheron N. Current treatment options for alcohol-related liver disease. Curr Opin Gastroenterol 2014;30:238-44. [PMID: 24662843 DOI: 10.1097/MOG.0000000000000065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
433 Altamirano J, Miquel R, Katoonizadeh A, Abraldes JG, Duarte-Rojo A, Louvet A, Augustin S, Mookerjee RP, Michelena J, Smyrk TC, Buob D, Leteurtre E, Rincón D, Ruiz P, García-Pagán JC, Guerrero-Marquez C, Jones PD, Barritt AS 4th, Arroyo V, Bruguera M, Bañares R, Ginès P, Caballería J, Roskams T, Nevens F, Jalan R, Mathurin P, Shah VH, Bataller R. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 2014;146:1231-9.e1-6. [PMID: 24440674 DOI: 10.1053/j.gastro.2014.01.018] [Cited by in Crossref: 263] [Cited by in F6Publishing: 284] [Article Influence: 29.2] [Reference Citation Analysis]
434 Lucey MR. Liver transplantation for alcoholic liver disease. Nat Rev Gastroenterol Hepatol 2014;11:300-7. [PMID: 24393837 DOI: 10.1038/nrgastro.2013.247] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 8.3] [Reference Citation Analysis]
435 Hashmi S, Allison MG, McCurdy MT, Reed RM. Hyperbilirubinaemia and haemolytic anaemia in acute alcoholic hepatitis: there's oil in them thar veins. BMJ Case Rep 2014;2014:bcr2014203804. [PMID: 24748143 DOI: 10.1136/bcr-2014-203804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
436 Lahmer T, Messer M, Schwerdtfeger C, Rasch S, Lee M, Saugel B, Schmid RM, Huber W. Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis. Mycopathologia. 2014;177:193-197. [PMID: 24710759 DOI: 10.1007/s11046-014-9740-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
437 Ma GD, Liu YH, Zhang QL, Zhang BG, Zhao N, Wang QL, Wang XD. Pre-endurance training prevents acute alcoholic liver injury in rats through the regulation of damaged mitochondria accumulation and mitophagy balance. Hepatol Int 2014;8:425-35. [PMID: 26202644 DOI: 10.1007/s12072-014-9529-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
438 Parker R, McCune CA. Diagnosis and treatment of alcoholic hepatitis. Frontline Gastroenterol 2014;5:123-9. [PMID: 28839759 DOI: 10.1136/flgastro-2013-100373] [Reference Citation Analysis]
439 Donckier V, Lucidi V, Gustot T, Moreno C. Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy. J Hepatol 2014;60:866-71. [PMID: 24291238 DOI: 10.1016/j.jhep.2013.11.015] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 8.9] [Reference Citation Analysis]
440 Singal AK, Kamath PS, Gores GJ, Shah VH. Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol 2014;12:555-64; quiz e31-2. [PMID: 23811249 DOI: 10.1016/j.cgh.2013.06.013] [Cited by in Crossref: 102] [Cited by in F6Publishing: 81] [Article Influence: 11.3] [Reference Citation Analysis]
441 Xu M, Chang B, Mathews S, Gao B. New drug targets for alcoholic liver disease. Hepatol Int 2014;8 Suppl 2:475-80. [PMID: 26201327 DOI: 10.1007/s12072-014-9516-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
442 Abenavoli L, Milic N, Rouabhia S, Addolorato G. Pharmacotherapy of acute alcoholic hepatitis in clinical practice. World J Gastroenterol 2014; 20(9): 2159-2167 [PMID: 24605014 DOI: 10.3748/wjg.v20.i9.2159] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
443 Kadian M, Kakkar R, Dhar M, Kaushik RM. Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis. J Gastroenterol Hepatol 2014;29:581-8. [PMID: 24117536 DOI: 10.1111/jgh.12400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
444 Hanouneh IA, Zein NN, Cikach F, Dababneh L, Grove D, Alkhouri N, Lopez R, Dweik RA. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. Clin Gastroenterol Hepatol 2014;12:516-23. [PMID: 24036050 DOI: 10.1016/j.cgh.2013.08.048] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 8.3] [Reference Citation Analysis]
445 Khalid T, Richardson P, Probert CS. The liver breath! Breath volatile organic compounds for the diagnosis of liver disease. Clin Gastroenterol Hepatol 2014;12:524-6. [PMID: 24211289 DOI: 10.1016/j.cgh.2013.10.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
446 Hanouneh IA, Zein NN, Cikach F, Dababneh L, Grove D, Alkhouri N, Lopez R, Dweik RA. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. Clin Gastroenterol Hepatol 2014;12:516-23. [PMID: 24036050 DOI: 10.1016/j.cgh.2013.08.048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
447 Aberg F, Helenius-Hietala J, Meurman J, Isoniemi H. Association between dental infections and the clinical course of chronic liver disease. Hepatol Res 2014;44:349-53. [PMID: 23607641 DOI: 10.1111/hepr.12126] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
448 Kwon HJ, Won YS, Park O, Feng D, Gao B. Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice. Hepatology 2014;59:1094-106. [PMID: 24115096 DOI: 10.1002/hep.26748] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
449 Gustot T, Maillart E, Bocci M, Surin R, Trépo E, Degré D, Lucidi V, Taccone FS, Delforge ML, Vincent JL, Donckier V, Jacobs F, Moreno C. Invasive aspergillosis in patients with severe alcoholic hepatitis. J Hepatol 2014;60:267-74. [PMID: 24055548 DOI: 10.1016/j.jhep.2013.09.011] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 9.6] [Reference Citation Analysis]
450 Kamimura K, Imai M, Sakamaki A, Mori S, Kobayashi M, Mizuno K, Takeuchi M, Suda T, Nomoto M, Aoyagi Y. Granulocytapheresis for the treatment of severe alcoholic hepatitis: a case series and literature review. Dig Dis Sci 2014;59:482-8. [PMID: 24052196 DOI: 10.1007/s10620-013-2871-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
451 Saison J, Berger F, Lebosse F, Audoual R, Thomas X, Michallet M. Hepatomegaly and fever at the time of neutrophil recovery revealing L-asparaginase toxicity in the treatment of acute lymphoblastic leukemia. Am J Case Rep 2014;15:13-7. [PMID: 24454976 DOI: 10.12659/AJCR.889867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
452 Latchoumycandane C, Nagy LE, McIntyre TM. Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation. Free Radic Biol Med 2014;69:403-16. [PMID: 24412858 DOI: 10.1016/j.freeradbiomed.2014.01.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
453 Kasten P. Alkoholinduzierte Leberschäden. SpringerReference Innere Medizin 2014. [DOI: 10.1007/978-3-642-54676-1_150-1] [Reference Citation Analysis]
454 Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, Pecker F, Tran A, Gual P, Mallat A, Lotersztajn S, Pavoine C. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 2014;59:130-42. [PMID: 23832548 DOI: 10.1002/hep.26607] [Cited by in Crossref: 346] [Cited by in F6Publishing: 358] [Article Influence: 38.4] [Reference Citation Analysis]
455 Schep LJ, Slaughter RJ, Vale JA, Wheatley P. Was the death of Alexander the Great due to poisoning? Was it Veratrum album? Clin Toxicol (Phila) 2014;52:72-7. [PMID: 24369045 DOI: 10.3109/15563650.2013.870341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
456 Sun X, Luo W, Tan X, Li Q, Zhao Y, Zhong W, Sun X, Brouwer C, Zhou Z. Increased plasma corticosterone contributes to the development of alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2013;305:G849-61. [PMID: 24113770 DOI: 10.1152/ajpgi.00139.2013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
457 Dhanda AD, Collins PL, McCune CA. Is liver biopsy necessary in the management of alcoholic hepatitis? World J Gastroenterol 2013; 19(44): 7825-7829 [PMID: 24307775 DOI: 10.3748/wjg.v19.i44.7825] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
458 Okazaki S, Nagoya S, Tateda K, Katada R, Mizuo K, Watanabe S, Yamashita T, Matsumoto H. Experimental rat model for alcohol-induced osteonecrosis of the femoral head. Int J Exp Pathol. 2013;94:312-319. [PMID: 24020403 DOI: 10.1111/iep.12035] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
459 Bysani M, Wallerman O, Bornelöv S, Zatloukal K, Komorowski J, Wadelius C. ChIP-seq in steatohepatitis and normal liver tissue identifies candidate disease mechanisms related to progression to cancer. BMC Med Genomics 2013;6:50. [PMID: 24206787 DOI: 10.1186/1755-8794-6-50] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
460 Bertola A, Park O, Gao B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology 2013;58:1814-23. [PMID: 23532958 DOI: 10.1002/hep.26419] [Cited by in Crossref: 203] [Cited by in F6Publishing: 194] [Article Influence: 20.3] [Reference Citation Analysis]
461 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of alcoholic liver disease. Clin Mol Hepatol. 2013;19:216-254. [PMID: 24133661 DOI: 10.3350/cmh.2013.19.3.216] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
462 Saunderson RB, Garsia R, Headley AP, McCaughan GW, O'Toole S, Strasser SI. Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. J Dermatol Case Rep 2013;7:77-81. [PMID: 24133560 DOI: 10.3315/jdcr.2013.1150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
463 Singal AK, Chaha KS, Rasheed K, Anand BS. Liver transplantation in alcoholic liver disease current status and controversies. World J Gastroenterol 2013; 19(36): 5953-5963 [PMID: 24106395 DOI: 10.3748/wjg.v19.i36.5953] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
464 Aravinthan A, Pietrosi G, Hoare M, Jupp J, Marshall A, Verrill C, Davies S, Bateman A, Sheron N, Allison M, Alexander GJ. Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease. PLoS One 2013;8:e72904. [PMID: 24086266 DOI: 10.1371/journal.pone.0072904] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
465 Abdelmegeed MA, Banerjee A, Jang S, Yoo SH, Yun JW, Gonzalez FJ, Keshavarzian A, Song BJ. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med. 2013;65:1238-1245. [PMID: 24064383 DOI: 10.1016/j.freeradbiomed.2013.09.009] [Cited by in Crossref: 125] [Cited by in F6Publishing: 132] [Article Influence: 12.5] [Reference Citation Analysis]
466 Thuluvath PJ, Ahn E, Nguyen GC. Hepatitis C as a prognostic indicator among noncirrhotic patients hospitalized with alcoholic hepatitis. Can J Gastroenterol 2013;27:639-42. [PMID: 24040630 DOI: 10.1155/2013/930827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
467 Forrest E, Mellor J, Stanton L, Bowers M, Ryder P, Austin A, Day C, Gleeson D, O'Grady J, Masson S, McCune A, Patch D, Richardson P, Roderick P, Ryder S, Wright M, Thursz M. Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials 2013;14:262. [PMID: 23958271 DOI: 10.1186/1745-6215-14-262] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
468 Warren KR, Murray MM. Alcoholic liver disease and pancreatitis: global health problems being addressed by the US National Institute on Alcohol Abuse and Alcoholism. J Gastroenterol Hepatol 2013;28 Suppl 1:4-6. [PMID: 23855288 DOI: 10.1111/jgh.12246] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
469 Kong X, Feng D, Mathews S, Gao B. Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. J Gastroenterol Hepatol 2013;28 Suppl 1:56-60. [PMID: 23855297 DOI: 10.1111/jgh.12032] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
470 Orman ES, Odena G, Bataller R. Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol 2013;28 Suppl 1:77-84. [PMID: 23855300 DOI: 10.1111/jgh.12030] [Cited by in Crossref: 164] [Cited by in F6Publishing: 172] [Article Influence: 16.4] [Reference Citation Analysis]
471 Fourman LT, Robert Meyer B. Autoimmune hepatitis in association with ramelteon. J Clin Gastroenterol 2013;47:651-4. [PMID: 23632362 DOI: 10.1097/MCG.0b013e31829174f0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
472 Trépo E, Ouziel R, Pradat P, Momozawa Y, Quertinmont E, Gervy C, Gustot T, Degré D, Vercruysse V, Deltenre P, Verset L, Gulbis B, Franchimont D, Devière J, Lemmers A, Moreno C. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. J Hepatol 2013;59:344-50. [PMID: 23557869 DOI: 10.1016/j.jhep.2013.03.024] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 7.9] [Reference Citation Analysis]
473 Pateria P, de Boer B, MacQuillan G. Liver abnormalities in drug and substance abusers. Best Pract Res Clin Gastroenterol 2013;27:577-96. [PMID: 24090944 DOI: 10.1016/j.bpg.2013.08.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
474 Wieser V, Tilg H. [Management of severe alcoholic hepatitis]. Wien Med Wochenschr 2014;164:3-8. [PMID: 23842647 DOI: 10.1007/s10354-013-0221-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
475 Matos L, Batista P, Monteiro N, Henriques P, Carvalho A. Hepatite alcoólica aguda - Artigo de revisão. GE Jornal Português de Gastrenterologia 2013;20:153-161. [DOI: 10.1016/j.jpg.2013.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
476 García-Ruiz C, Kaplowitz N, Fernandez-Checa JC. Role of Mitochondria in Alcoholic Liver Disease. Curr Pathobiol Rep 2013;1:159-68. [PMID: 25343061 DOI: 10.1007/s40139-013-0021-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
477 Singal AK, Salameh H, Singal A, Jampana SC, Freeman DH, Anderson KE, Brunder D. Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians. World J Gastrointest Pharmacol Ther 2013; 4(2): 16-22 [PMID: 23667769 DOI: 10.4292/wjgpt.v4.i2.16] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
478 Parker R, Armstrong MJ, Corbett C, Rowe IA, Houlihan DD. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Aliment Pharmacol Ther 2013;37:845-54. [PMID: 23489011 DOI: 10.1111/apt.12279] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 7.5] [Reference Citation Analysis]
479 Mathews S, Gao B. Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease. Hepatology 2013;57:2078-80. [PMID: 23609413 DOI: 10.1002/hep.26336] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
480 Gandoura S, Weiss E, Rautou PE, Fasseu M, Gustot T, Lemoine F, Hurtado-Nedelec M, Hego C, Vadrot N, Elkrief L, Lettéron P, Tellier Z, Pocidalo MA, Valla D, Lebrec D, Groyer A, Monteiro RC, de la Grange P, Moreau R. Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis. J Hepatol 2013;58:936-48. [PMID: 23321315 DOI: 10.1016/j.jhep.2012.12.025] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
481 Singal AK, Anand BS. Recent trends in the epidemiology of alcoholic liver disease. Clin Liver Dis. 2013;2:53-56. [PMID: 30992823 DOI: 10.1002/cld.168] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
482 Hardy T, Wells C, Kendrick S, Hudson M, Day CP, Burt AD, Masson S, Stewart SF. White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers. BMC Gastroenterol 2013;13:55. [PMID: 23530737 DOI: 10.1186/1471-230X-13-55] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
483 Rolas L, Makhezer N, Hadjoudj S, El-Benna J, Djerdjouri B, Elkrief L, Moreau R, Périanin A. Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis. Hepatology 2013;57:1163-71. [PMID: 23080369 DOI: 10.1002/hep.26109] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
484 Affò S, Dominguez M, Lozano JJ, Sancho-Bru P, Rodrigo-Torres D, Morales-Ibanez O, Moreno M, Millán C, Loaeza-del-Castillo A, Altamirano J, García-Pagán JC, Arroyo V, Ginès P, Caballería J, Schwabe RF, Bataller R. Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut 2013;62:452-60. [PMID: 22637703 DOI: 10.1136/gutjnl-2011-301146] [Cited by in Crossref: 134] [Cited by in F6Publishing: 124] [Article Influence: 13.4] [Reference Citation Analysis]
485 Wang Y, Hu Y, Chao C, Yuksel M, Colle I, Flavell RA, Ma Y, Yan H, Wen L. Role of IRAK-M in alcohol induced liver injury. PLoS One. 2013;8:e57085. [PMID: 23437317 DOI: 10.1371/journal.pone.0057085] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
486 Smathers RL, Galligan JJ, Shearn CT, Fritz KS, Mercer K, Ronis M, Orlicky DJ, Davidson NO, Petersen DR. Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver. J Lipid Res 2013;54:1335-45. [PMID: 23359610 DOI: 10.1194/jlr.M034892] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
487 Støy S, Sandahl TD, Dige AK, Agnholt J, Rasmussen TK, Grønbæk H, Deleuran B, Vilstrup H. Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course. PLoS One 2013;8:e55101. [PMID: 23372820 DOI: 10.1371/journal.pone.0055101] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
488 Enjoji M, Yasutake K, Kohjima M, Nakamuta M. Nutrition and Alcoholic and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol. Alcohol, Nutrition, and Health Consequences 2013. [DOI: 10.1007/978-1-62703-047-2_40] [Reference Citation Analysis]
489 Caballeria J, Michelena J, Altamirano J. Nutrition in Alcoholic Steatohepatitis. Alcohol, Nutrition, and Health Consequences 2013. [DOI: 10.1007/978-1-62703-047-2_42] [Reference Citation Analysis]
490 A. Ferri's Clinical Advisor 2013 2013. [DOI: 10.1016/b978-0-323-08373-7.00010-8] [Reference Citation Analysis]
491 Fernando H, Wiktorowicz JE, Soman KV, Kaphalia BS, Khan MF, Shakeel Ansari GA. Liver proteomics in progressive alcoholic steatosis. Toxicol Appl Pharmacol 2013;266:470-80. [PMID: 23200777 DOI: 10.1016/j.taap.2012.11.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
492 Medici V, Halsted CH. Folate, alcohol, and liver disease. Mol Nutr Food Res. 2013;57:596-606. [PMID: 23136133 DOI: 10.1002/mnfr.201200077] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 6.8] [Reference Citation Analysis]
493 Schwartz JM, Reinus JF. Prevalence and natural history of alcoholic liver disease. Clin Liver Dis 2012;16:659-66. [PMID: 23101975 DOI: 10.1016/j.cld.2012.08.001] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 8.1] [Reference Citation Analysis]
494 Singal AK, Charlton MR. Nutrition in alcoholic liver disease. Clin Liver Dis 2012;16:805-26. [PMID: 23101983 DOI: 10.1016/j.cld.2012.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
495 Selzner N. Liver Disease Due to Alcohol. Hepatology: Diagnosis and Clinical Management 2012. [DOI: 10.1002/9781118314968.ch15] [Reference Citation Analysis]
496 Singal AK, Kuo YF, Anand BS. Hepatitis C virus infection in alcoholic hepatitis: prevalence patterns and impact on in-hospital mortality. Eur J Gastroenterol Hepatol 2012;24:1178-84. [PMID: 22735607 DOI: 10.1097/MEG.0b013e328355cce0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
497 Antar R, Wong P, Ghali P. A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis. Can J Gastroenterol. 2012;26:463-467. [PMID: 22803023 DOI: 10.1155/2012/945707] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
498 Kleiner DE, Berman D. Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma. Dig Dis Sci 2012;57:2233-40. [PMID: 22434096 DOI: 10.1007/s10620-012-2140-5] [Cited by in Crossref: 106] [Cited by in F6Publishing: 106] [Article Influence: 9.6] [Reference Citation Analysis]
499 European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012;57:399-420. [PMID: 22633836 DOI: 10.1016/j.jhep.2012.04.004] [Cited by in Crossref: 450] [Cited by in F6Publishing: 470] [Article Influence: 40.9] [Reference Citation Analysis]
500 Galligan JJ, Smathers RL, Shearn CT, Fritz KS, Backos DS, Jiang H, Franklin CC, Orlicky DJ, Maclean KN, Petersen DR. Oxidative Stress and the ER Stress Response in a Murine Model for Early-Stage Alcoholic Liver Disease. J Toxicol. 2012;2012:207594. [PMID: 22829816 DOI: 10.1155/2012/207594] [Cited by in Crossref: 63] [Cited by in F6Publishing: 75] [Article Influence: 5.7] [Reference Citation Analysis]
501 Sidhu SS, Goyal O, Singla P, Gupta D, Sood A, Chhina RS, Soni RK. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial). Dig Dis Sci 2012;57:1664-71. [PMID: 22388710 DOI: 10.1007/s10620-012-2097-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
502 Sancho-Bru P, Altamirano J, Rodrigo-Torres D, Coll M, Millán C, José Lozano J, Miquel R, Arroyo V, Caballería J, Ginès P, Bataller R. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 2012;55:1931-41. [PMID: 22278680 DOI: 10.1002/hep.25614] [Cited by in Crossref: 143] [Cited by in F6Publishing: 132] [Article Influence: 13.0] [Reference Citation Analysis]
503 Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology 2012;55:1398-405. [PMID: 22213344 DOI: 10.1002/hep.25544] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 10.8] [Reference Citation Analysis]
504 Caballería J, Altamirano J, Michelena J, Parés A. Enfermedad hepática inducida por el alcohol. Medicine - Programa de Formación Médica Continuada Acreditado 2012;11:581-589. [DOI: 10.1016/s0304-5412(12)70352-9] [Reference Citation Analysis]
505 Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, Agostini H, Njike M, Barri-Ova N, Naveau S, Le Marchand-Brustel Y, Veillon P, Calès P, Perlemuter G, Tran A, Gual P. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 2012;7:e35612. [PMID: 22530059 DOI: 10.1371/journal.pone.0035612] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 5.8] [Reference Citation Analysis]
506 Wang HJ, Gao B, Zakhari S, Nagy LE. Inflammation in alcoholic liver disease. Annu Rev Nutr. 2012;32:343-368. [PMID: 22524187 DOI: 10.1146/annurev-nutr-072610-145138] [Cited by in Crossref: 193] [Cited by in F6Publishing: 204] [Article Influence: 17.5] [Reference Citation Analysis]
507 Wells JT, Lucey MR. Alcoholic liver diseases. Textbook of Clinical Gastroenterology and Hepatology 2012. [DOI: 10.1002/9781118321386.ch88] [Reference Citation Analysis]
508 Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World J Hepatol 2012; 4(3): 81-90 [PMID: 22489260 DOI: 10.4254/wjh.v4.i3.81] [Cited by in Crossref: 118] [Cited by in F6Publishing: 127] [Article Influence: 10.7] [Reference Citation Analysis]
509 Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol 2012;27 Suppl 2:89-93. [PMID: 22320924 DOI: 10.1111/j.1440-1746.2011.07003.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 141] [Article Influence: 12.4] [Reference Citation Analysis]
510 Zhu H, Jia Z, Misra H, Li YR. Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. J Dig Dis 2012;13:133-42. [PMID: 22356308 DOI: 10.1111/j.1751-2980.2011.00569.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 117] [Article Influence: 9.9] [Reference Citation Analysis]
511 Mallat A, Teixeira-Clerc F, Deveaux V, Manin S, Lotersztajn S. The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings. Br J Pharmacol. 2011;163:1432-1440. [PMID: 21457226 DOI: 10.1111/j.1476-5381.2011.01397.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 7.7] [Reference Citation Analysis]
512 Mathurin P, Lucey MR. Management of alcoholic hepatitis. J Hepatol 2012;56 Suppl 1:S39-45. [PMID: 22300464 DOI: 10.1016/S0168-8278(12)60005-1] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 8.4] [Reference Citation Analysis]
513 Chalasani NP. Alcoholic and Nonalcoholic Steatohepatitis. Goldman's Cecil Medicine 2012. [DOI: 10.1016/b978-1-4377-1604-7.00155-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
514 Lemasters JJ, Holmuhamedov EL, Czerny C, Zhong Z, Maldonado EN. Regulation of mitochondrial function by voltage dependent anion channels in ethanol metabolism and the Warburg effect. Biochim Biophys Acta. 2012;1818:1536-1544. [PMID: 22172804 DOI: 10.1016/j.bbamem.2011.11.034] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
515 Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572-85. [PMID: 21920463 DOI: 10.1053/j.gastro.2011.09.002] [Cited by in Crossref: 1218] [Cited by in F6Publishing: 1292] [Article Influence: 101.5] [Reference Citation Analysis]
516 Singal AK, Jampana SC, Weinman SA. Antioxidants as therapeutic agents for liver disease. Liver Int 2011;31:1432-48. [PMID: 22093324 DOI: 10.1111/j.1478-3231.2011.02604.x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 152] [Article Influence: 12.3] [Reference Citation Analysis]
517 Gramenzi A, Gitto S, Caputo F, Biselli M, Lorenzini S, Bernardi M, Andreone P. Liver transplantation for patients with alcoholic liver disease: an open question. Dig Liver Dis 2011;43:843-9. [PMID: 21550324 DOI: 10.1016/j.dld.2011.03.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
518 González Quintela A. Los corticoides mejoran la supervivencia a corto plazo en los pacientes con hepatitis alcohólica grave: metaanálisis de datos de pacientes individuales. Revista Clínica Española 2011;211:478-479. [DOI: 10.1016/j.rce.2011.05.010] [Reference Citation Analysis]
519 Louvet A, Teixeira-Clerc F, Chobert MN, Deveaux V, Pavoine C, Zimmer A, Pecker F, Mallat A, Lotersztajn S. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 2011;54:1217-26. [PMID: 21735467 DOI: 10.1002/hep.24524] [Cited by in Crossref: 183] [Cited by in F6Publishing: 176] [Article Influence: 15.3] [Reference Citation Analysis]
520 Miller AM, Wang H, Bertola A, Park O, Horiguchi N, Ki SH, Yin S, Lafdil F, Gao B. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice. Hepatology 2011;54:846-56. [PMID: 21725996 DOI: 10.1002/hep.24517] [Cited by in Crossref: 116] [Cited by in F6Publishing: 115] [Article Influence: 9.7] [Reference Citation Analysis]
521 Liangpunsakul S. Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States. J Clin Gastroenterol 2011;45:714-9. [PMID: 21085006 DOI: 10.1097/MCG.0b013e3181fdef1d] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
522 Singal AK, Shah VH. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am 2011;40:611-39. [PMID: 21893277 DOI: 10.1016/j.gtc.2011.06.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
523 Sandahl TD, Jepsen P, Ott P, Vilstrup H. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol 2011;46:1127-32. [PMID: 21591871 DOI: 10.3109/00365521.2011.587200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
524 Singal AK, Walia I, Singal A, Soloway RD. Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current status. World J Hepatol 2011; 3(8): 205-210 [PMID: 21954408 DOI: 10.4254/wjh.v3.i8.205] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
525 Singal AK, Duchini A. Liver transplantation in acute alcoholic hepatitis: Current status and future development. World J Hepatol 2011; 3(8): 215-218 [PMID: 21954410 DOI: 10.4254/wjh.v3.i8.215] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
526 Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol 2011;8:491-501. [PMID: 21826088 DOI: 10.1038/nrgastro.2011.134] [Cited by in Crossref: 203] [Cited by in F6Publishing: 205] [Article Influence: 16.9] [Reference Citation Analysis]
527 Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ. Treatment of alcoholic liver disease. Therap Adv Gastroenterol. 2011;4:63-81. [PMID: 21317995 DOI: 10.1177/1756283x10378925] [Cited by in Crossref: 97] [Cited by in F6Publishing: 107] [Article Influence: 8.1] [Reference Citation Analysis]
528 Lucey MR. Liver transplantation in patients with alcoholic liver disease. Liver Transpl 2011;17:751-9. [PMID: 21567894 DOI: 10.1002/lt.22330] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 7.2] [Reference Citation Analysis]
529 Dupont B, Dao T, Piquet M-. Hépatite alcoolique aiguë : prise en charge en 2011. Réanimation 2011;20:335-342. [DOI: 10.1007/s13546-011-0276-5] [Reference Citation Analysis]
530 Fernando H, Bhopale KK, Kondraganti S, Kaphalia BS, Shakeel Ansari GA. Lipidomic changes in rat liver after long-term exposure to ethanol. Toxicol Appl Pharmacol 2011;255:127-37. [PMID: 21736892 DOI: 10.1016/j.taap.2011.05.022] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
531 Bharrhan S, Koul A, Chopra K, Rishi P. Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. PLoS One. 2011;6:e20635. [PMID: 21673994 DOI: 10.1371/journal.pone.0020635] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 5.1] [Reference Citation Analysis]
532 Basra S, Anand BS. Definition, epidemiology and magnitude of alcoholic hepatitis. World J Hepatol 2011; 3(5): 108-113 [PMID: 21731902 DOI: 10.4254/wjh.v3.i5.108] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
533 Basra G, Basra S, Parupudi S. Symptoms and signs of acute alcoholic hepatitis. World J Hepatol 2011; 3(5): 118-120 [PMID: 21731904 DOI: 10.4254/wjh.v3.i5.118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
534 Braillon A. Severe alcoholic hepatitis: Glucocorticoid saves lives and transplantation is promising. World J Gastroenterol 2011; 17(19): 2454-2454 [PMID: 21633648 DOI: 10.3748/wjg.v17.i19.2454] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
535 Wang H, Lafdil F, Kong X, Gao B. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci. 2011;7:536-550. [PMID: 21552420 DOI: 10.7150/ijbs.7.536] [Cited by in Crossref: 174] [Cited by in F6Publishing: 192] [Article Influence: 14.5] [Reference Citation Analysis]
536 Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. J Hepatol 2011;54:760-4. [PMID: 21126790 DOI: 10.1016/j.jhep.2010.07.016] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 8.2] [Reference Citation Analysis]
537 Lavallard VJ, Bonnafous S, Patouraux S, Saint-Paul MC, Rousseau D, Anty R, Le Marchand-Brustel Y, Tran A, Gual P. Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease. PLoS One. 2011;6:e17599. [PMID: 21445263 DOI: 10.1371/journal.pone.0017599] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
538 Smathers RL, Galligan JJ, Stewart BJ, Petersen DR. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem Biol Interact. 2011;192:107-112. [PMID: 21354120 DOI: 10.1016/j.cbi.2011.02.021] [Cited by in Crossref: 113] [Cited by in F6Publishing: 301] [Article Influence: 9.4] [Reference Citation Analysis]
539 Vaa BE, Asrani SK, Dunn W, Kamath PS, Shah VH. Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clin Proc. 2011;86:37-42. [PMID: 21193654 DOI: 10.4065/mcp.2010.0281] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
540 Yerian L. Histopathological evaluation of fatty and alcoholic liver diseases. J Dig Dis 2011;12:17-24. [PMID: 21091934 DOI: 10.1111/j.1751-2980.2010.00472.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
541 Saxena R. Nonneoplastic Hepatobiliary Disease. Essentials of Anatomic Pathology 2011. [DOI: 10.1007/978-1-4419-6043-6_44] [Reference Citation Analysis]
542 Choulis N. Miscellaneous drugs, materials, medical devices, and techniques. Side Effects of Drugs Annual 2011. [DOI: 10.1016/b978-0-444-53741-6.00049-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
543 Suchy FJ. Drug- and Toxin-Induced Liver Injury. Nelson Textbook of Pediatrics 2011. [DOI: 10.1016/b978-1-4377-0755-7.00355-9] [Reference Citation Analysis]
544 . Health Consequences of Alcohol Intake. Handbook of Alcoholic Beverages 2010. [DOI: 10.1002/9780470976524.ch38] [Reference Citation Analysis]
545 Rautou PE, Mansouri A, Lebrec D, Durand F, Valla D, Moreau R. Autophagy in liver diseases. J Hepatol 2010;53:1123-34. [PMID: 20810185 DOI: 10.1016/j.jhep.2010.07.006] [Cited by in Crossref: 302] [Cited by in F6Publishing: 308] [Article Influence: 23.2] [Reference Citation Analysis]
546 Braillon A. Sciensationalism. Am J Med 2011;124:e13. [PMID: 20887967 DOI: 10.1016/j.amjmed.2010.07.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
547 Stickel F, Seitz HK. Alcoholic steatohepatitis. Best Pract Res Clin Gastroenterol 2010;24:683-93. [PMID: 20955970 DOI: 10.1016/j.bpg.2010.07.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
548 Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R, Gao B. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010;52:1291-300. [PMID: 20842630 DOI: 10.1002/hep.23837] [Cited by in Crossref: 309] [Cited by in F6Publishing: 316] [Article Influence: 23.8] [Reference Citation Analysis]
549 Ray I, Dutta D, Basu P, De BK. Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire. Indian J Gastroenterol 2010;29:187-95. [PMID: 20740340 DOI: 10.1007/s12664-010-0036-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
550 Aithal GP. Defining 'acute on chronic liver failure': an identity crisis! Indian J Gastroenterol 2010;29:177-80. [PMID: 21038104 DOI: 10.1007/s12664-010-0057-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
551 Petrasek J, Mandrekar P, Szabo G. Toll-like receptors in the pathogenesis of alcoholic liver disease. Gastroenterol Res Pract. 2010;2010:710381. [PMID: 20827314 DOI: 10.1155/2010/710381] [Cited by in Crossref: 65] [Cited by in F6Publishing: 74] [Article Influence: 5.0] [Reference Citation Analysis]
552 Mathurin P. The use of corticosteroids in severe alcohol hepatitis: we need to look beyond this controversy. J Hepatol 2010;53:392-3. [PMID: 20537754 DOI: 10.1016/j.jhep.2010.03.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
553 Aroor AR, James TT, Jackson DE, Shukla SD. Differential changes in MAP kinases, histone modifications, and liver injury in rats acutely treated with ethanol. Alcohol Clin Exp Res. 2010;34:1543-1551. [PMID: 20586759 DOI: 10.1111/j.1530-0277.2010.01239.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
554 Singal AK. Comment on ACG Guidelines--Management of alcoholic liver disease. Am J Gastroenterol 2010;105:1449-50. [PMID: 20523323 DOI: 10.1038/ajg.2010.144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
555 Dureja P, Lucey MR. The place of liver transplantation in the treatment of severe alcoholic hepatitis. J Hepatol 2010;52:759-64. [PMID: 20347501 DOI: 10.1016/j.jhep.2009.12.021] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
556 Miranda-Mendez A, Lugo-Baruqui A, Armendariz-Borunda J. Molecular basis and current treatment for alcoholic liver disease. Int J Environ Res Public Health. 2010;7:1872-1888. [PMID: 20622998 DOI: 10.3390/ijerph7051872] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
557 Lv X, Chen Z, Li J, Zhang L, Liu H, Huang C, Zhu P. Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress. Inflamm Res. 2010;59:635-645. [PMID: 20221667 DOI: 10.1007/s00011-010-0176-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
558 Marik PE. Alcoholic Hepatitis. Handbook of Evidence-Based Critical Care 2010. [DOI: 10.1007/978-1-4419-5923-2_34] [Reference Citation Analysis]
559 Müller-marbach A, Häussinger D, Rump L, Vonend O. Das hepatorenale Syndrom. Nephrologe 2010;5:29-42. [DOI: 10.1007/s11560-009-0339-z] [Reference Citation Analysis]
560 Whitfield K, Rambaldi A, Wetterslev J, Gluud C. Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev 2009;:CD007339. [PMID: 19821406 DOI: 10.1002/14651858.CD007339.pub2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 63] [Article Influence: 3.1] [Reference Citation Analysis]